South Dakota State University

Open PRAIRIE: Open Public Research Access Institutional
Repository and Information Exchange
Electronic Theses and Dissertations
2019

Development of Tissue-Derived Biomaterial ‘Cornea-ECMIX’: Its
Utility in the Management of Corneal Diseases
Somshuvra Bhattacharya
South Dakota State University

Follow this and additional works at: https://openprairie.sdstate.edu/etd
Part of the Optometry Commons, and the Pharmacy and Pharmaceutical Sciences Commons

Recommended Citation
Bhattacharya, Somshuvra, "Development of Tissue-Derived Biomaterial ‘Cornea-ECMIX’: Its Utility in the
Management of Corneal Diseases" (2019). Electronic Theses and Dissertations. 3255.
https://openprairie.sdstate.edu/etd/3255

This Thesis - Open Access is brought to you for free and open access by Open PRAIRIE: Open Public Research
Access Institutional Repository and Information Exchange. It has been accepted for inclusion in Electronic Theses
and Dissertations by an authorized administrator of Open PRAIRIE: Open Public Research Access Institutional
Repository and Information Exchange. For more information, please contact michael.biondo@sdstate.edu.

DEVELOPMENT OF TISSUE-DERIVED BIOMATERIAL ‘CORNEA-ECMIX’: ITS
UTILITY IN THE MANAGEMENT OF CORNEAL DISEASES

BY
SOMSHUVRA BHATTACHARYA

A dissertation submitted in partial fulfillment of the requirements for the
Doctor of Philosophy
Major in Pharmaceutical Sciences
South Dakota State University
2019

iii

ACKNOWLEDGEMENTS

Completing this thesis work has been a tremendous journey of learning,
perseverance and new experiences for me. I want to express my gratitude to several
individuals, without whom this work would not have been possible.
Firstly, I would like to express my deepest thanks and heartfelt gratitude to my
major thesis advisor, Chandrasekher Gudiseva, without whom this work would not have
been possible. He has been my source of inspiration with his passion for science, and it has
been a privilege for me to have worked under his supervision. Dr. Chandrasekher has
always amazed me with his constant foresight and incredible cues to connect significant
scientific leads. His inputs have been valuable to my academic and scientific development.
He has not only mentored me to be a better scientist but has also advised me in every step
of the journey, on how to become a better person. I am incredibly grateful for all the
guidance and support he has provided me throughout this work. From continually keeping
an open door for me to obtain advice when experiments did not work to suggestions on
matter beyond research, Dr. Chandrasekher’s supportive nature has helped mold my career
efficiently. I have enjoyed every single interaction with him and will treasure all our
conversations about science and life.
Dr. Gunaje, Dr. Tummala, and Dr. Perumal have been my other three pillars of
encouragement and support during my time in South Dakota State University. Every time
I have faced a problem, I have had their doors open for advice as well. From guidance
about life to nurturing scientific ideas, they have been my anchor in all the challenges that
I have come across. I am grateful for every bit of their time, advice and guidance.

iv

I would also like to take this opportunity to thank my Doctoral committee members,
Dr. Perumal, Dr. Tummala and Dr. Xu. They have always lent me countless hours of their
valuable time so that I may ask questions and get their answers appropriately. Since the
last five years, they have been a tremendous support to my research with their constant
encouragement, scientific ideas and critical appreciation of my work. Their advice and
corrections have been crucial to this work and have helped shape the project in many ways.
My peers, Jacob Sandgren (Jake), and Josephine Ausdemore (Josie) who were
undergraduate research interns in our lab were instrumental for a large chunk of the work
presented in this thesis. Jake was the pioneering spearhead for the ECMIX-Glutaraldehyde
gel work and his contributions to the ideas, techniques and results related to this segment
were pivotal. Both Jake and Josie spent countless hours accompanying me on trips to
collect research tissues and helped me harvest them for research. From discussing scientific
ideas in the lab to planning several outings after a heavy week of work, they have never
been one step behind to ensure that life was not dull in the lab.
This work has been a significant learning curve for me, and I would like to thank
the entire Department of Pharmaceutical Sciences in South Dakota State University faculty, postdoctoral fellows and fellow graduate students who have been alongside me
throughout this journey.
Finally, my sincere gratitude goes to my parents, Mr. Baidyanath Bhattacharjee and
Mrs. Jaya Bhattacharya. If not for their love, and constant support, the efforts I have tried
to put in while doing this work would not have been possible. Although they have been
miles away in a different country, they had always made sure that their blessings reached
me when I needed them most.

v

TABLE OF CONTENTS

LIST OF ABBREVIATIONS………………………………………………………….. xi
LIST OF FIGURES…………………………………………………….………....…… xv
LIST OF TABLES……………………………………………………………...….... xviii
ABSTRACT…………………………………………………………...……………… xix
CHAPTER 1: INTRODUCTION...………………….…………………………………. 1
1.1. The Extracellular matrix……………………...……………………………. 1
1.2. Collagens in the ECM……………...………………………………………. 2
1.3. Fibronectin in the ECM…………………………………………………….. 6
1.4. Laminins in ECM………………………………..………………………….. 8
1.5. Glycosaminoglycans in the ECM………………………………………..….. 9
1.6. ECM in different tissues……...……………………………………………. 10
1.7. ECM in the eye……………………………………………………………. 12
1.8. The cornea: Structure and Function……………………………………….. 15
1.8.1. The corneal stroma………………………………………………. 17
1.8.2. Corneal stroma in maintaining tissue health…………...…………. 18
CHAPTER 2: GENERAL METHODS...……………………………………………….. 22
2.1. Materials……………………………………………………………………. 22
2.1.1. Cell culture……………………………………………………….. 22
2.1.2. Electrophoresis and Western blot reagents…………….………… 23

vi

2.1.3. Cell proliferation and glucose assay kits……………………….......25
2.1.4. Protein markers…………………………………………………… 25
2.1.5. Primary antibodies………………………………………………... 25
2.1.6. Secondary antibodies……………………………………...……… 27
2.1.7. Collagenase enzymes……………………………………………... 27
2.1.8. Miscellaneous………………………..………………………….. 28
2.2. Methods……………….……………………………………………………. 28
2.2.1. Preparation of corneal tissues for cell culture…………………… 28
2.2.2. Corneal epithelial cell culture..…………………………………… 29
2.2.3. Corneal fibroblast cell culture..………………………………..… 29
2.2.4. Preparation of cell lysate…………………………………………. 30
2.2.5. Protein estimation………………………………………..………. 30
2.2.6. SDS-PAGE and Western immunoblotting ……………………… 31
2.2.6.1. Electrophoresis……….………………….………..…… 31
2.2.6.2. Western immunoblotting….……………..………..…… 31
2.2.7. CytQuant Cell proliferation assay……..…………………...…….. 32
2.2.8. Ex-vivo organ culture studies using of intact eye globes ………..... 33
2.2.9. Scanning electron microscopy (SEM) studies…………………….. 34
2.2.10. Optical properties………………………………………….…… 34
2.2.11. Rheological (viscosity and viscoelastic) properties…….………. 34
2.2.12. Swelling/hydration experiments………………………………… 35

vii

2.2.13. Glucose permeation studies…..……………...………………….. 35
CHAPTER 3: RELEASE OF EXTRACELLULAR MATRIX PROTEINS FROM
CORNEA IN RESPONSE TO INJURY: ITS RELEVANCE TO EPITHELIAL
REGENERATION..…………………………………………………………………….. 37
3.1. Introduction...………………………………………………………………. 37
3.2. Methods…....……………………………………………….………………. 40
3.2.1. Cornea ex-vivo organ culture….…………………………………. 40
3.2.2. Identification of ECM proteins in COCM by SDS-PAGE/Western
immunoblotting……………………………………………………….….40
3.2.3. Digestibility of ECM proteins in COCM by collagenase.………... 41
3.2.4. Effect of COCM on epithelial cell regeneration.…………………. 41
3.2.5. Statistical analysis ……………………….………………………. 42
3.3. Results..…....……………………………………………….………………. 42
3.3.1. Enhanced release of ECM proteins from the cornea after epithelial
injury……………………………………………………………………. 42
3.3.2. Collagenous nature of the ECM proteins released into COCM..… 42
3.3.3. Secretion Kinetics of Collagen I, Collagen IV and Fibronectin release
following corneal epithelial injury …………………………………...…. 43
3.3.4. The molecular size of released ECM proteins is similar to corneal
stromal extracellular matrix components ……………………………...…43
3.3.5 Evaluation of corneal stromal ECM protein degrading capability of
COCM ………………………………………………………………...…44

viii

3.3.6. COCM promotes epithelial cell proliferation ……………………..45
3.3.7. COCM promoted epithelial cell attachment and regeneration on the
epithelial debrided human cornea surface……………………………….. 45
3.4. Discussion....……………………………………………….………………. 45
CHAPTER 4: CORNEA ECMIX: A NOVEL TISSUE-DERIVED BIOMATERIAL - ITS
DEVELOPMENT, CHARACTERIZATION AND CLINICAL APPLICATIONS...….. 48
4.1. Introduction...………………………………………………………………. 48
4.2. Methods…....……………………………………………….………………. 51
4.2.1. Preparation of corneal extracellular matrix mixture (ECMIX)…… 51
4.2.2. Identification of ECMIX components……….…………………… 52
4.2.3. Scanning electron microscopy analysis…………………………... 52
4.2.4. Effect of ECMIX on corneal epithelial ERK and PI3-K/Akt
activation…………………………………………………………………52
4.2.5. Effect of ECMIX on corneal epithelial cell cycle protein
expression……………………………………………………………….. 53
4.2.6. Effect of ECMIX on epithelial cell regeneration in corneas incubated
under organ-culture conditions …………………………………………..53
4.2.7. Statistical Analysis…………………………………………….…. 53
4.3. Results..…....……………………………………………….………………. 54
4.3.1. ECM preparation and components identified in ECMIX…..…..… 54
4.3.2. Organization of the fibrillar network in ECMIX: Analyzing ECMIX
by using Scanning electron microscopy (SEM) analysis ….…………..

54

ix

4.3.3. Activation of ERK and PI3-k/Akt by ECMIX.………………….. 55
4.3.4. Upregulation of corneal epithelial cell cycle protein expression by
ECMIX……………………………………………………………..…….55
4.3.5. ECMIX supported epithelial cell regeneration in corneas subjected to
epithelial injury ……………………………………………………...…. 57
4.4. Discussion....……………………………………………….…….………… 58
CHAPTER 5: BIOENGINEERING AND CHARACTERIZATION OF ECMIX-BASED
CORNEAL CONSTRUCTS FOR TRANSPLANTATION ...………………………….. 61
5.1. Introduction...………………………………………………………………. 61
5.2. Methods…....……………………………………………….………………. 63
5.2.1. Viscosity and viscoelasticity properties of ECMIX……….…...… 63
5.2.2. Fabrication of ECMIX constructs …...……………...….………… 63
5.2.3. Optical properties of ECMIX and ECMIX construct………………64
5.2.4. SEM analysis of ECMIX constructs ………………………….…. 64
5.2.5. Evaluation of ECMIX construct’s degree of swelling …………

65

5.2.6. Evaluation of ECMIX construct’s glucose permeation property.…65
5.2.7. Evaluation of effects of proteolytic activity, temperature and time
stability of ECMIX constructs …………………………………………...65
5.2.7. Evaluation of corneal cell growth on ECMIX constructs ………. 66
5.2.8. Evaluation of cell growth pattern on ECMIX constructs…………...67
5.3. Results..…....……………………………………………….……………… 67
5.3.1. Rheological properties of ECMIX………………..….………..… 67

x

5.3.2. Fabrication of ECMIX constructs……………………………..… 69
5.3.3. Optical properties of ECMIX …………..…...…………………… 69
5.3.4. ECMIX constructs retained corneal fiber organization …………... 70
5.3.5. ECMIX constructs possess acceptable degree of swelling ………. 70
5.3.6. Glucose permeation through ECMIX constructs ….…..……….

71

5.3.7. Stability of ECMIX constructs under various conditions……...…. 71
5.3.8. Corneal cell growth on ECMIX constructs………………………. 72
5.4. Discussion....……………………………………………….…….………… 73
CHAPTER 6: SUMMARY AND CONCLUSIONS……...…………………………….. 77
BIBLIOGRAPHY……………………………………………………………………

128

xi

LIST OF ABBREVIATIONS

µg

Microgram

µL

Microliter

µM

Micrometer

0

Degree Celsius

C

Akt/PKB

Protein kinase B

ANOVA

Analysis of variance

APS

Ammonium persulfate

BSA

Bovine serum albumin

Cdc42

Cell division cylcle protein 42

CDK

Cyclin dependant kinase

COCM

Cornea organ culture conditioned medium

Col I

Collagen type I

Col IV

Collagen type IV

DAPI

4′,6-diamidino-2-phenylindole

DMEM/F12

Dulbecco’s modified Eagle Medium-Ham’s F-12

DNA

Deoxyribo nucleic acid

DTT

Dithiothreitol

EBMD

Epithelial basement membrane dystrophy

ECL

Enhanced chemiluminescence

xii

ECM

Extracellular Matrix

ECMIX

Corneal extracellular matrix mixture

EGF

Epidermal growth factor

EGTA

Ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic acid

ERK

Extracellular-signal-regulated kinase

FACIT

Fibril-associated collagen with interrupted triple helices

FBS

Fetal bovine serum

FITC

Fluorescein isothiocyanate

FN

Fibronectin

G’

Shear modulus

G”

Loss modulus

GAG

Glycosaminoglycan

HCEC

Human corneal epithelial cell

HEPES

4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid

HGF

Hepatocyte growth factor

HRP

Horseradish peroxidase

Hz

Hertz

IGF

Insulin-like growth factor

IPM

Interphotoreceptor matrix

kDa

Kilo Dalton

KGF

Keratinocyte growth factor

xiii

lbs

Pounds

MgCl2

Magnesium chloride

ml

Milliliter

mm

Millimeter

mM

Millimolar

MMP

Matrix metalloproteinase

mRNA

Messenger RNA

mTorr

Millitorr

MWCO

Molecular weight cut-off

NaCl

Sodium chloride

NaOH

Sodium hydroxide

nm

Nanometer

Pa

Pascal

PAGE

Polyacrylamide gel electrophoresis

PBS

Phosphate-buffered saline

PCEC

Pig corneal epithelial cell

PDGF

Platelet-derived growth factor

PI3K

Phosphoinositide 3-kinase

PMSF

Phenylmethylsulfonyl fluoride

RCES

Recurrent corneal erosion syndrome

RI

Refractive index

xiv

rpm

Revolutions per minute

SD

Standard deviation

SDS

Sodium dodecyl sulfate

SEM

Scanning electron microscope

SLRP

Small leucine-rich repeat proteoglycan

T-25

Tissue culture flask 25 cm2 surface area

TBS

20 mM Tris-HCl pH 7.4, 150 mM NaCl

TEMED

Tetramethylethylenediamine

TGF-β

Transforming growth factor beta

TIMP

Tissue inhibitor of metalloproteinase

TTBS

20 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.05% Tween-20

UV

Ultraviolet

VEGF

Vascular endothelial growth factor

xv

LIST OF FIGURES

Figure 1: The Extracellular matrix……………………………………………………... 81
Figure 2A: The Collagen triple-helix .………………………………………………..... 82
Figure 2B: Distribution of amino acids in the collagen triple-helix…………………..... 83
Figure 3: Collagen Fibers………...…………………………………………………..... 84
Figure 4: Collagen fibers observed using TEM and AFM…………………………….. 85
Figure 5: Cascade of events leading to collagen synthesis……………………………… 86
Figure 6: Collagen intramolecular crosslinking…………………………………………. 87
Figure 7: Chemical structures of different types of GAGs present in the ECM………… 88
Figure 8: GAG linkage to core protein in a proteoglycan……………………………..

89

Figure 9A: Eye transverse scan………….. …………………………………………….. 90
Figure 9B: The cross-section of the eye……………………………………………….. 90
Figure 10: The corneal stroma………………………………………………………… 91
Figure 11: The corneal epithelial layers………………………………………….…….. 92
Figure 12: Corneal stromal repair…………………………………………………..…… 93
Figure 13: Corneal cell isolation……………………………………………………..….. 94
Figure 14: ECM protein secretion kinetics from porcine corneas……………………… 95
Figure 15: Ex-vivo organ culture /ECMIX on human/porcine corneas………..………

96

Figure 16: ECM peptides released from corneas after epithelial debridement……..…… 97
Figure 17: Confirmation of collagenous nature of released ECM proteins……….…… 98

xvi

Figure 18: Differences in secretion amount of during 0-60 hours……………………. ...99
Figure 19: Differences in secretion pattern of released during 0-60 hours……………...100
Figure 20: Proteolytic effect of COCM on stromal proteins……………………………. 101
Figure 21: COCM promotes epithelial proliferation………………………….……….. 102
Figure 22: Ex vivo organ culture studies using COCM on human corneas…………….. 103
Figure 23: Possible wound-healing roles attributed to the released ECM peptides….. 104
Figure 24: ECMIX preparation scheme……………………………………………… 105
Figure 25: Composition of ECMIX………………………………………………….. 106
Figure 26: SEM micrographs of ECMIX and stroma of the human cornea…………… 107
Figure 27: Activation of intracellular signal mediators ERK and Akt by ECMIX……. 108
Figure 28: ECMIX enhanced CDK expressions……………………………………….. 109
Figure 29: ECMIX-mediated cell-cycle protein expression…………………………… 110
Figure 30: ECMIX promoted epithelial cell sheets on porcine corneas……………….. 111
Figure 31: ECMIX promoted epithelial sheets on human corneas……………………. 112
Figure 32: Rheological characteristics of ECMIX……………………………………. 113
Figure 33A: Fabrication of ECMIX construct………………..……………………….. 114
Figure 33B: Chemistry involved in crosslinking ECMIX…………………………….. 114
Figure 34: Optical properties of ECMIX……………………………………………… 115
Figure 35: Optical properties of ECMIX constructs..………………………………… 116
Figure 36: Scanning electron micrographs of ECMIX construct..……………………. 117
Figure 37: Degree of swelling in ECMIX constructs as a function of time……………. 118

xvii

Figure 38: Glucose permeation through ECMIX constructs………………………….. 119
Figure 39: Corneal cell growth on ECMIX constructs………………………………… 120
Figure 40A: Epithelial cells generated from the expressed Cytokeratin-3…………….…121
Figure 40B: Epithelial cells growing on the construct acquired multiple layers……… 122
Figure 40C: Properties of corneal cells growing on ECMIX constructs ……..……..… 123
Figure 41: Sustainability of cell growth on ECMIX constructs……….………………. 124

xviii

LIST OF TABLES

Table 1: Major ECM components………………………,……………………….……. 125
Table 2: Major ECM components in the eye…………………………………………. 126

xix

ABSTRACT
DEVELOPMENT OF TISSUE-DERIVED BIOMATERIAL ‘CORNEA-ECMIX’: ITS
UTILITY IN THE MANAGEMENT OF CORNEAL DISEASES
SOMSHUVRA BHATTACHARYA
2019

Transparent cornea, at the front of the eye, mediates vision by refracting incoming
light. Due to its anatomical position, cornea is susceptible to a variety of physical and
chemical insults. Severe damage caused to cornea due to trauma or disease conditions can
impair vision. While the cornea’s inherent repair mechanism restores partial vision loss,
transplantation is the only viable treatment option if its transparency is completely lost. A
global shortage of transplantable donor tissues necessitates the need for the development
of functional corneal prosthetics. As cornea mostly is made up of extracellular matrix
(ECM), several studies have explored the utility of ECM components such as collagens
and proteoglycans to fabricate corneal replacements. However, replaceable devices made
of these materials so far did not produce desirable outcomes in patients due to a variety of
reasons. Employment of a biomaterial that closely mimics the native corneal composition
is very critical for the development of corneal replacements. An ideal corneal substitute
should also be able to harbor the epithelium which is critical to maintaining tissue function.
Therefore, we have considered it worthwhile to utilize the ECM of cornea for preparing a
therapeutic platform that can be useful not only for producing corneal replacements but
also for treating multiple vision impairing corneal disorders. The work presented in this
thesis shows that corneal ECM components can promote epithelial cell regeneration.
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Further, a biomaterial is prepared from the cornea tissue itself, referred to as cornea
ECMIX, and it is employed to design a construct whose characteristics and functionality
is evaluated.
The content included in Chapter 1 (Introduction) describes the relevant literature
related to research presented in this thesis. The topics covered include a description of
ECM components and how ECM components may vary between tissue to tissue. This
chapter also discusses the corneal ECM microenvironment, and its importance for
maintaining tissue health.
List of various materials, chemicals and descriptions of general methods employed
to perform the experiments are presented in Chapter 2.
The results presented in Chapter 3 shows the secretion kinetics of three corneal
ECM components (Collagen I, Collagen IV and Fibronectin) in response to corneal
epithelial injury. The medium containing these components also promoted epithelial cell
growth. The observations from this chapter signify the importance of cornea-derived ECM
components on epithelial cell regeneration.
In order to utilize intrinsic corneal ECM for therapeutic applications, we have
described a method to liquefy cornea in its entirety (ECMIX), that is described in Chapter
4. To the best of our knowledge, currently there is no other method available to completely
solubilize the cornea in this manner. The process of this method is proprietary, and a U.S.
patent has been filed (October 2017-Tissue-Derived Biomaterial composition and methods
for Ocular and other Therapeutic Applications - US Patent Pending). ECMIX stimulated
growth promoting intracellular signaling mechanisms and upregulated cell cycle protein
expression in corneal epithelium. Further, we demonstrated the ability of ECMIX to
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regenerate epithelium on human corneas. ECMIX growth promoting potential can be
attributed to the collective influence of multiple native corneal ECM components.
Optical (transmittance and refractive index), rheological (viscosity and
viscoelasticity) properties of ECMIX and its employment for the fabrication of a corneal
replacement are described in Chapter 5. The fibrillar collagen arrangement in ECMIX
construct and human corneas was comparable as evidenced by scanning electron
microscope analysis. Further, the prepared constructs were evaluated for temperature
stability, susceptibility to proteolytic degradation, swelling capacity, and glucose
permeability. Constructs supported the growth of corneal cells (epithelium and fibroblasts).
In conclusion, our studies highlight that engineering of ECM-based therapeutic
devices for regeneration of damaged ocular surface is worthy of consideration. Corneal
ECMIX and ECMIX-construct that are developed in this research work are beneficial
platforms to treat recurrent corneal epithelial erosions and other corneal dystrophies where
the presence of a healthy ECM is very critical. ECMIX-based therapeutic devices could
regenerate epithelial cells on ocular surfaces and replace damaged human corneas. In the
era of 3D printing of organs, ECMIX, whose composition approximates that of the native
corneal tissue could serve as bio-ink to print corneas for transplantation purposes.
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CHAPTER 1
INTRODUCTION

1.1. The Extracellular Matrix
The extracellular matrix (ECM) is a porous ground structure that supports cell
attachment and growth in all connective tissues. Connective tissues acquire their strength
and rigidity from the ECM and its surrounding interstitial fluids. ECM comprises a highly
organized network of various types of collagens, elastins, proteoglycans, and
noncollagenous glycoproteins that help form a complex, three-dimensional tissue
architecture in an organ-specific manner (Frantz, Stewart, & Weaver, 2010), as illustrated
in Figure 1.
Proteoglycans comprise the majority of extracellular interstitial space. They have
several functions that reflect their buffering, hydration, and exogenous force-resistance
properties. Proteoglycans contain glycosaminoglycan (GAG) chains covalently linked to a
protein core (except hyaluronic acid) (Iozzo & Murdoch, 1996). GAG chains connected to
the protein core are unbranched polysaccharide chains containing repeating disaccharide
units. Differences in GAG composition and core protein build can result in a large number
of proteoglycans. Depending on whether the GAG chain is sulfated or not, proteoglycan
types can vary as well (sulfated: chondroitin sulfate, keratan sulfate) and (non-sulfated:
hyaluronic acid) (Schaefer & Schaefer, 2010). GAG molecules generate the hydrated, gellike niche in which collagens remain embedded (Pelosi, Rocco, Negrini, & Passi, 2007).
The primary function of the GAG complex in tissue ECM is to provide it mechanical
support while simultaneously allowing the diffusion of water-soluble molecules and cell
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migration (Murphy, O’Brien, Little, & Schindeler, 2013). A gel-like consistency of the
ECM is essential to resist compressive forces that are imposed on the matrix, while the
surrounding collagen fiber system provides the necessary tensile strength (Humphrey,
Dufresne, & Schwartz, 2014). Table 1 lists the most commonly reported ECM components.
The difference in the relative amounts and types of macromolecules present within the
ECM and their nature of organization eventually determine the biomechanical properties
of the respective tissue (Schwartz, 1982).

1.2. Collagens in the ECM
The most abundantly found proteins in the ECM are collagens, and almost 28
different types of collagens have been identified (Shoulders & Raines, 2009). Collagens
attribute tensile strength to the tissues and help maintain a high level of structural integrity.
A collagen molecule contains two identical α-1 chains and one α-2 chain that is folded to
form a triple helix, as shown in Figure 2A (Bailey, 1987). The molecular weight of the α1 chain is 139 kDa, and α-2 is 129 kDa (Rabotyagova, Cebe, & Kaplan, 2008). Collagens
are rich in amino acids proline, hydroxyproline, and glycine. In all collagens, the triple
helical domain consists of Gly-X-Y repeats, as illustrated in Figure 2B. (Shoulders &
Raines, 2009). To form the right-handed triple helix, it is essential that glycine be present
in every third position (Shoulders & Raines, 2009). The conformation of proline and
hydroxyproline rings can either be endo, i.e., pointing towards the residue peptide bond or
exo, i.e., looking away from the peptide bond. Each proline/hydroxyproline ring
conformation is affiliated with a different backbone structure. The rings on both proline
and hydroxyproline can flip rapidly between the endo and exo conformations, with proline
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sustaining an angular reorientation of ∼30° (Goldberga, Li, & Duer, 2018). This unique
feature is useful to assess specific ring conformation. Studies have revealed that prolines
have a metastable structure and significant conformational diversity at physiologically
relevant temperatures. A small amount of energy is needed for Gly-Pro-Hyp prolines to tilt
within the conformational range represented by proline endo-exo ring flipping, yet a lot
more strength is necessary to alter the proline rings (and therefore the collagen backbone)
(Chow et al., 2015). This metastability confers rigidity and stability to the coil. Further, the
glycine side chain fits into the cramped center of the triple helix. Hydrogen bonds
connecting the -NH of the glycine residue with a -CO group in an adjacent polypeptide
fasten the three chains together (Park, Klein, & Pande, 2007). One bond forms between the
-NH and -CO group of a glycyl residue in the second position of the triplet, and the other
one between a water molecule at the third position of the triplet which leads to the
formation of additional hydrogen bonds using the hydroxyl group of hydroxyproline
(Berisio, Vitagliano, Mazzarella, & Zagari, 2002). A unique fixed angle of the C–N
peptidyl-proline/hydroxyproline bond helps each polypeptide chain to fold in a way such
that the three chains can twist together to form the triple helix (Park et al., 2007).
Collagens have chiefly three levels of arrangement: trimer, fibril, and fiber.
Individual collagen polypeptides self-assemble into trimers in the endoplasmic reticulum.
Trimer assembly into fibrils takes place outside the cell. If this assembly occurs between
three identical polypeptides, the result is a homotrimer. Collagen type II is an example of
a homotrimeric protein. Covalent crosslinks between trimers increase the mechanical
strength of collagen fibrils (Figure 6). Some fibrils self-assemble into fibers. Collagens
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also show variations in the degree of glycosylation, that is the covalent coupling of glucose
and galactose to the parent molecules.
Electron microscopy studies have shown that collagens fiber strands are
approximately 1 to 100 µM thick. (Ushiki, 2002). Fibers are a bundle of tightly packed thin
fibrils that are about 10 nm thick (Figure 3 and 4). About 1000 microfibrils aggregate
laterally and end-to-end to form a fibril possessing diameter of 80-100 nm (Bi et al., 2005).
Collagen fibrils are cylindrically shaped with a diameter ranging from 10 to 500 nm with
periodic striations, which are classified as A-E bands (Lingham-Soliar & Wesley-Smith,
2008). The occurrence of these striations depends on the length of the two closest D-bands.
The diameter of collagen fibrils vary significantly; for example, corneal collagen fibrils
have a diameter of 30 nm while those of the sclera is about 25-230 nm (Meek, 2009).
Collagen fibril diameter in tendons and ligaments have been reported to be between 100200 nm (Goh, Holmes, Lu, Kadler, & Purslow, 2018).
Collagen fibril formation occurs as a result of several orchestrated complex intracellular and extracellular biochemical events (Figure 5). First, procollagen, which is the
precursor to collagen, is assembled, whose principal components are the amino acids
glycine and proline (Muiznieks & Keeley, 2013). Approximately 45 genes, each having a
"COL" prefix are typically responsible for coding for the k sequence associated with
collagen formation (Shoulders & Raines, 2009).
During the process of translation, two peptide chains are formed on the ribosomes
along the rough endoplasmic reticulum (RER). These are called the α1 and α2
preprocollagen chains. These peptide chains possess unique registration peptides on each
end along with a signal peptide. Following formation, the preprocollagen chains are
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released into the RER lumen. Inside the RER, the signal peptides get cleaved after which
the peptide chains are known as pro- α chains. Hydroxylation of amino acids lysine and
proline takes place also inside the lumen with ascorbic acid (Vitamin C) as a cofactor. Next,
glycosylation of the hydroxylysine residues occurs. The triple helical structure takes shape
inside the endoplasmic reticulum from two α1 chains and one α2 chain. This is referred to
as procollagen. Procollagen is then translocated into the Golgi apparatus, where it is
packaged and secreted outside the cell by exocytosis. Once outside the cell, the registration
peptides get cleaved, and tropocollagen is formed by procollagen peptidase. Tropocollagen
molecules assemble to form collagen fibrils, via covalent cross-linking by lysyl oxidase
which links hydroxylysine and lysine residues and multiple collagen fibrils form collagen
fibers. Collagen molecules eventually remain attached to cell membranes via several types
of protein, including fibronectin and integrin.
Approximately 500 thin fibrils help form a collagen fiber (Caves et al., 2010).
These fibers aggregate into fiber bundles with a thickness between 10 and 100 µm
(Shoulders & Raines, 2009). The size and shape of collagen fibers (consisting of thin
fibrils) varies even within the same species. Studies have shown that the copolymerization
between collagen molecules within the same fibril and with other ECM components is
critical to the final diameter of the fibril (Muiznieks & Keeley, 2013; Rouede et al., 2017).
In skin and tendons, where the goal is to form dense connective tissue, the collagen fibers
usually acquire a cord shape with a width of 1-20 µM and follow a wavy course (Silver,
Freeman, & Seehra, 2003). This curved arrangement helps to serve as a cushion against
direct tension applied to the fibers.
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The morphological arrangement of collagens varies with their type and tissue
location. For example, type I collagen form fibers, type II collagen are not as organized as
type I fibers (Antipova & Orgel, 2010). Type III collagen forms fibers which are much
thinner than type I/II and that help organize cells within organs (Gordon & Hahn, 2010).
Type IV collagens form branched networks that help hold the basement membrane
(Yurchenco, 2011). Collagens type IX and XII, help mediate the organization of collagen
fibrils in different tissues by regulating the interactions between the fibers and other ECM
molecules (Luo et al., 2017). For example, in the skin, the collagen network is present as a
woven pattern that can resist tensile stresses from multiple directions. Similarly, in tendons,
the collagen fibrils are arranged in bundles and aligned along the axis of tension (Wenger,
Bozec, Horton, & Mesquida, 2007). In corneas, fibrils lay parallel to each other, but
perpendicular to fibrils in adjacent layers (Michelacci, 2003). The typical arrangement of
the fibers in the cornea is critical to the transparency of the tissue. Here, the collagen fibers
remain significantly oriented, allowing the tissue to have the right biomechanical strength
yet be entirely transparent for incoming light waves (Hassell & Birk, 2010).

1.3. Fibronectin in the ECM
Fibronectin (FN) is another essential component of the ECM. It is one of the most
abundantly distributed multidomain glycoprotein present in almost all types of tissue. It
has a molecular weight of 230 to 260 kDa. A substantial amount can also be detected in
the plasma (Halper & Kjaer, 2014).
FN occurs as a dimer and comprises two nearly identical ∼250 kDa subunits that
are linked covalently near their C-terminals by a pair of disulfide bonds (Pankov, 2002).
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Each FN monomer includes types I, II, and III repeating units which are also called as FN
repeats: type I, type II and type III (Brown, Dysart, Clarke, Stabenfeldt, & Barker, 2015).
FN contains 12 type I repeats, two type II repeats and 15-17 type III repeats (Pankov, 2002).
These collectively account for almost 90% of the FN sequence. Type I repeats are 40
amino-acid residues in length and contain two disulfide bonds; type II repeats consist of 60
amino acids and two intrachain disulfide bonds, while type III repeats are about 90 residues
long without any disulfide bonds. (Patel et al., 1987). Type III modules are produced by
seven stranded β-barrel structures that lack disulfide linkages entirely (Przybysz,
Borysewicz, & Katnik-Prastowska, 2013). The FN domains mediate self-assembly and
promote ligand binding for collagens, heparin, FN, and other ECM molecules (Singh,
Carraher, & Schwarzbauer, 2010).
FN exists in multiple isoforms that are formed by alternative splicing and is widely
expressed in regions of cell migration and during inflammation (White, Baralle, & Muro,
2008). FN levels are always observed to be elevated in tissues undergoing repair (e.g.,
wound healing). During matrix assembly, multivalent ECM proteins self- associate and
interact with each other and form fibrillar networks (Kubow et al., 2015). Matrix assembly
is usually initiated by FN binding to cell surface receptors such as α5β1 integrin
(Wierzbicka-Patynowski & Schwarzbauer, 2003; Singh et al. ,2010). Binding to the
receptor mediates FN self-association and organizes the actin cytoskeleton to generate cell
contractility (Singh et al., 2010). Once completely assembled, the FN matrix affects tissue
organization by contributing to the assembly of different ECM proteins (Brennan &
Hocking, 2016; Sevilla, Dalecki, & Hocking, 2010). FN plays a vital role in the cascade of
fibrillogenesis (Llopis-Hernandez, Rico, Moratal, Altankov, & Salmeron-Sanchez, 2013).
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1.4. Laminins in ECM
Laminin is a critical component in basement membranes of tissues. These are crossshaped heterotrimers comprising α1, β1, and γ1 chains. Eleven distinct chains of laminins
have been identified in humans (Macdonald, Lustig, Steinmetz, & Kammerer, 2010). The
molecular weight of laminin is 220 kDa (Aumailley, 2013).
The distribution of laminin chains is tissue and cell-specific. Some variations are
observed between developmental and pathological states. For example, laminin 111
heterotrimer containing the α1 chain is expressed during the embryonic stage, but it is
absent in adult basement membranes (Sasaki et al., 2010). Similarly, laminin heterotrimers
containing the α5 chain like laminins 511 and 521, are ubiquitously expressed in adults but
are absent in embryonic stages (Sasaki et al., 2010).
Laminin isoform distribution within tissues is also diverse. Laminins 211 and 221
are well known constituents of skeletal and cardiac muscle basement membranes (Gawlik
& Durbeej, 2011), whereas laminins 411 and 421 are present in endothelial basement
membranes (Yousif, Di Russo, & Sorokin, 2013) and laminin 332 in basal lamina
underlying epithelial cells (Walko, Castanon, & Wiche, 2015). This distribution diversity
of laminins attribute molecular heterogeneity to the tissue basement membrane.
In laminin heterotrimers, a long arm is generated by similarly sized amino acid
stretches (561-591 residues depending on the chain) present at the C-terminus of the β and
γ chains and the neighboring portion of the α chain (Aumailley, 2013). This laminin Cterminus α chain is 865–900 residues longer compared to the β and γ chains. This stretch
is rich in heptad repeats of non-polar amino acids (Paulsson et al., 1985). An additional
31–33 amino acid residues insert between these heptad repeats of all three β chains forming
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a knob, called the β knob, generating the long arm (Barlow, Green, Kurkinen, & Hogan,
1984). Under in-vitro conditions, laminin chains assemble into polygonal lattices with the
help of calcium-dependent interactions. Although laminin assembly under in-vivo
conditions occurs by the same mechanism, these conditions need the laminin long arm to
be tethered to cell surface receptors (Colognato & Yurchenco, 2000). The laminin Cterminal ends interact with the plasma membrane, hence relaying critical biochemical
signals between intracellular and extracellular molecular networks. On the other hand, the
N-terminal ends of laminins are available for interactions with other basement membrane
ECM molecules. Laminins in basement membranes meditate epithelial cell adhesion and
help regulate their presentation to nearby cells.

1.5. Glycosaminoglycans in the ECM
Glycosaminoglycans make up less than 10% by weight of all ECM components.
These are polysaccharide chains containing repeating disaccharide units. For example,
hyaluronic acid contains up to 25,000 units of a non-sulfated disaccharide (Bathe,
Rutledge, Grodzinsky, & Tidor, 2005). The chemical structures of different GAGs are
shown in Figure 7. The elasticity of hyaluronic acid can be attributed to the self-association
between repeating glucuronic acid and N-acetylglucosamine units (Fallacara, Baldini,
Manfredini, & Vertuani, 2018). Other typical examples of GAGs include chondroitin
sulfate and dermatan sulfate. Chondroitin has the same basic structure as hyaluronic acid,
with only N-acetylgalactosamine replacing N-acetylglucosamine.
When GAGs covalently bind to proteins, they are called proteoglycans.
Proteoglycans contain one or more GAG chains attached to a core protein. Their function
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is to support collagen binding within the ECM. Proteoglycans bind to collagen and in doing
so, regulate inter-fibrillar spacing and enhance their crosslinking. Except for hyaluronic
acid, all GAGs are covalently attached to a protein to form a proteoglycan. Figure 8 depicts
the link between a GAG chain and a core protein via a trisaccharide in a proteoglycan
molecule.
Proteoglycans vary significantly by the repeating disaccharide units that comprise
their GAG chains (Couchman & Pataki, 2012; Victor et al., 2009). An example of a
commonly found proteoglycan in the ECM is decorin. Decorin is a low molecular weight
proteoglycan which contains just one dermatan-sulfate GAG chain, and it gets such a name
because of the way it "decorates" the collagen fibrils (Smith & Melrose, 2015). Decorin
binds to and regulates collagen fibril arrangement and orientation. Decorin has also shown
to alter fibril diameter, affecting whether a thick or thin collagen fibril would be generated.
It is the only molecule capable of recapitulating the in-vivo structure of type I collagen invitro (Orgel, Eid, Antipova, Bella, & Scott, 2009). The association between collagen and
proteoglycans are essential to maintaining ECM homology.

1.6. ECM in different tissues
ECM surrounds cells in multicellular organisms. All connective tissues are
embedded in the extracellular material. The type and composition of ECM vary depending
on the organ functionality, and this niche provides mechanical support to many soft parts
of the body like ear, ligaments, tendons, and the cornea. The bone matrix contains collagen
fibers and mineral deposits. The ECM in bone includes a high amount of calcium
phosphate, although magnesium, carbonate, and fluoride ions are also present. The cells

11

that help synthesize ECM include fibroblasts, chondroblasts for cartilage, and osteoblasts
for bone.
ECM-rich dense and loose connective tissues distributed throughout the body have
a stroma. The stroma comprises of the basement membrane, fibroblasts, extracellular
matrix, immune cells, and vasculature. It is reported that over 300 proteins make up the
mammalian ECM more commonly referred to as the “core matrisome” (Hynes & Naba,
2012). This family does not include the relatively large number of ECM-associated
proteins. Stromal cells remodel the ECM through degradation and reassembly. The
dynamic nature of the ECM becomes apparent during injuries, trauma, and certain
dystrophies when these processes get accelerated.
The ECM responds to signals from growth factors such as EGF, KGF, VEGF, HGF,
IGF, and interleukins which are believed to regulate healing and development (Borena et
al., 2015; Kim et al., 2010; Ma et al., 2014; Seeger & Paller, 2015; Valluru, Staton, Reed,
& Brown, 2011; Y. H. Yang et al., 2016). There are various connective tissues where a
stroma is present. Some of these include the stroma in the iris, which contains the pigment
granules that ultimately impact the variable eye color seen in variable human populations
(P Vogel, 2008). Stroma in the thyroid gland supports the lobules and follicles (Vidinov,
Vidinov, Kalniev, & Krastev, 2013) while the stroma in the thymus helps to initiate T cell
development from hematopoietic progenitor cells (Taghon, David, Zuniga-Pflucker, &
Rothenberg, 2005).
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1.7. ECM in the eye
The eye is an asymmetrical sphere having a sagittal diameter of 24 to 25 mm and a
transverse width of 24 mm sitting in a cone-shaped cavity in the skull (Shrestha &
Dhungana, 2013). The volume of this cavity is 6.5 cubic centimeter (Bekerman, Gottlieb,
& Vaiman, 2014). This cavity also called an eye-socket, is held in position by various
ligaments and muscles (Figure 9A).
Figure 9B illustrates the structures that constitute the eye. The sclera is the white,
outer part that supports the entire structure of the eye. Sclera comprises a portion of the
supporting boundary of the whole eyeball and is continuous with the cornea. The cornea is
the transparent tissue that helps refract light as it enters the eye. It covers both the pupil
and the iris. The pupil is located at the center of the iris, and it is the opening through which
light passes into the eye. Iris controls the pupil size, hence regulating the amount of light
that enters the eye. Variations in iris color occur due to variable amounts of eumelanin
(brown/black melanins) and pheomelanin (red/yellow melanins) produced by melanocytes
(Le Pape, Wakamatsu, Ito, Wolber, & Hearing, 2008). The lens is another transparent
structure in the eye behind the iris that helps to focus incoming light onto the retina, and it
can change its shape so that the eye can focus on objects at various distances. The
transparent lens is suspended by ligaments called zonule fibers attached to the anterior
portion of the ciliary body. The retina is present at the back of the eye and contains
photoreceptor cells (that is, rod and cone cells) which help transmit light to the brain and
form an image.
The eye structure and shape are influenced mainly by its ECM-rich tissues,
including the cornea, lens, vitreous, sclera, and retina. Several ECMs are present in the

13

vertebrate eye (Table 2). Although ECM composition overlaps between tissues, the
physiological role of these molecules is unique to each location. From maintaining tissue
transparency to helping corneal epithelial cell growth, the corneal stromal ECM plays a
pivotal role in the maintenance of tissue structure (Michelacci, 2003). As the bulk of the
cornea is primarily composed of the ECM-rich stroma, the importance of these molecules
in the maintenance of tissue health is of paramount importance. The corneal stroma and its
ECM composition are discussed in detail later.
The sclera is almost entirely made up of ECMs, and collagens constitute
approximately 90% of the scleral weight. Most of the scleral fibroblastic cells are of neural
crest origin, but a small number originates from the mesenchyme surrounding the new
eyecup (Williams & Bohnsack, 2015). The collagens and proteoglycans of the scleral
matrix have been extensively studied (Wessel et al., 1997; Rada et al., 2000 and Watson
and Young, 2004). Majority of the scleral matrix studies have been driven by the changes
that the tissue undergoes during myopia. The sclera is a dynamic tissue that is continuously
reorganizing itself employing different matrix-modifying enzymes (Maquart et al., 2005;
Siegwart, Jr. and Norton, 2005; VanSaun and Matrisian, 2006; Wride et al., 2006) and
result in collagen fibrillar rearrangement (McBrien et al., 2000; Gentle et al., 2001;
McBrien and Gentle, 2003; Rada et al., 2000; Austin et al., 2002; Siegwart, Jr. and Norton,
2002; Dunlevy and Rada, 2004).
The retina is the primary neural tissue in the eye, and the roles ECM play in its
development have been studied extensively (Al-Ubaidi, Naash, & Conley, 2013; Bishop,
2015; Reinhard, Joachim, & Faissner, 2015). Several signaling molecules like Wnts, FGF,
BMP, TGF-β and hedgehog proteins, are critical to the development and functioning of the
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retina (J. Li et al., 2016; Messina et al., 2015; Zhang et al., 2013). Work done by multiple
groups has established the presence of many glycosaminoglycans in the developing retina
including heparan sulfate, small leucine repeat-rich proteins (SLRPs) decorin, biglycan,
lumican and fibromodulin (Morris and Ting, 1981; Inatani and Tanihara, 2002). The
specific role of heparan sulfate in neuronal and glial differentiation, photoreceptor
differentiation has also been extensively studied (Merhi-Soussi et al., 2006). Researchers
have shown that the SLRP opticin, which is also present in the vitreous, helps bind the
retinal growth hormone (Sanders, Walter, Parker, Ara´mburo, & Harvey, 2003). Retinal
stratification has also been shown to be directed by laminins, present in the outer plexiform
layer (Libby et al., 2000). The α6b1 integrin dimer has been reported to be the primary
laminin receptor in the retina (Bradshaw et al., 1995).
Although the presence of ECM is evident in the vertebrate eye (Table 2), many of
these molecules are present selectively at different stages of tissue development. Hence,
certain ECMs which are widely present during embryonic development might be absent in
adulthood. For example, osteonectin does not appear in the retina during the midembryonic stage and is only found in adult tissues (Botti et al., 2014; Rosset & Bradshaw,
2016). Thus, it is unlikely to play a role in early ocular tissue formation. However,
osteonectin is expressed abundantly in the lens during the developmental stage indicating
its possible role in initial cell adhesion to the matrix (Brekken and Sage, 2001; Yan et al.,
2003; Weaver et al., 2006).
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1.8. The cornea: Structure and function
The cornea is the avascular tissue located on the anterior part of the eye.
(Friedlander, 2007). This transparent tissue is strong and durable and helps provide the
primary barrier to the rest of the eye by shielding it from germs, dust, and other harmful
matter (Eghrari & Gottsch, 2010). The cornea also acts as the eye's outer lens regulating
the flow of light into the organ. The cornea accounts for 65 to 75 percent of the eye's total
focusing power (Chang, Lin, & Zhang, 2017). The lens that separates the anterior and
posterior chambers of the eye then further refocuses these rays onto the retina, which
eventually translates these light rays into vision. The cornea also serves as a UV filter,
effectively screening out the majority of damaging ultraviolet (UV) wavelengths in
sunlight (Majdi, Milani, Movahedan, Wasielewski, & Djalilian, 2014). Without this
function of the cornea, the underlying lens and the retina would be highly susceptible to
UV injury.
As illustrated in Figure 10, the corneal tissue consists of five primary layers, each
having an important function (Reinstein, Archer, Gobbe, Silverman, & Coleman, 2009)
(Ang et al., 2016), The outermost most layer is the 50 µm multilayered epithelium,
comprising about 10 percent of the tissue's thickness (Torricelli & Wilson, 2014). The
epithelium is responsible primarily for blocking the passage of foreign material, such as
dust, water, and germs, into the eye. The epithelium comprises hundreds of tiny nerve
endings that make the cornea extremely sensitive to pain when rubbed or scratched
(Gonzalez-Gonzalez, Bech, Gallar, Merayo-Lloves, & Belmonte, 2017). The basement
membrane is that part of the epithelium that serves as the foundation on which epithelial
cells anchor and organize themselves (Laibson, 2010). Lying directly below the epithelial
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basement membrane is a transparent sheet of tissue composed of collagens, known as the
Bowman's layer. Once injured, Bowman's layer forms a scar. If these scars are centrally
located, loss of vision can occur (S. E. Wilson, Marino, Torricelli, & Medeiros, 2017).
Lying underneath the Bowman’s layer is the 400-500 µm thick stroma, which
represents about 90 percent of the cornea's thickness, (Chen, Mienaltowski, & Birk, 2015).
The corneal stroma contains sparsely distributed cells throughout its depth called
keratocytes. Keratocytes are mesenchymal-derived cells that are generally quiescent but
can readily transition into repair phenotypes (called fibroblasts) following injury. These
cells help turn over the ECM in the stroma and are exclusively responsible for maintaining
cornea's transparency. Stroma gives the corneal tissue its strength, elasticity, and shape.
The stroma’s transparency is essential in mediating the cornea's refracting capability
(Hassell & Birk, 2010). Just below the stroma is the Descemet’s membrane, a thin but
strong tissue sheet that acts as a potential barrier against infection and injuries. Studies have
shown that Descemet's membrane can regenerate readily after injury (Galan, Catania, &
Giudice, 2016).
The last and innermost corneal layer is the thin endothelium. The corneal
endothelium comprises a monolayer of cells that regulate corneal nutrition and hydration
utilizing a semipermeable barrier through which active ion transport takes place. The
endothelium's task is to control the movement of aqueous humor into the corneal stroma
through a pumping action (Eghrari & Gottsch, 2010; Peh, Beuerman, Colman, Tan, &
Mehta, 2011). Without the endothelial pumping action, the stroma would swell with water
eventually becoming hazy and opaque. Human corneal endothelial cells do not regrow after
they are destroyed and hence are lost forever. If too many endothelial cells are damaged,
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corneal edema and blindness can occur, with corneal transplantation the only available
therapy (Van den Bogerd, Dhubhghaill, Koppen, Tassignon, & Zakaria, 2017).
Although the health of each layer is critical for the normal functioning of the tissue,
during disease or injury, especially when the epithelium is damaged, it is mostly the stroma
that generates signaling cues to mediate an orchestrated healing response (Ljubimov &
Saghizadeh, 2015). It has been reported that after injury growth factors like HGF and KGF
get upregulated in the stroma (Q. Li et al., 1996).

1.8.1. The corneal Stroma
The corneal stroma is a reservoir of growth factors, cytokines, proteins,
polysaccharides, and cells that accumulate to mitigate damage gained from external
injuries by promoting cell regeneration and healing. Collagen is a significant component
that make up the stromal architecture (Bailey, 1987; Newsome, Gross, & Hassell, 1982).
A tissue whose primary function is helping vision needs to be transparent to transmit visible
light. Hence, maintaining transparency is critical for the functioning of the stroma.
Physiologically, transparency is retained by the maintenance of collagen fibril
concentration (Chen et al., 2015), diameters, uniform thickness and lamellae organization
in the stromal assembly (Chakravarti, Zhang, Chervoneva, Roberts, & Birk, 2006; Qazi,
Wong, Monson, Stringham, & Ambati, 2010). By studying the natural corneal stroma, we
would be better equipped to develop therapeutic systems that can simulate these natural
interactions and improve treatment for multiple corneal dystrophies.
Corneal stromal transparency is achieved through the uniform diameter and orderly
packing of the constituent collagen fibrils (Ruberti & Zieske, 2008), keratan sulfate
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proteoglycans that regulate an optimal collagen fibril diameter and spacing (Meek &
Knupp, 2015; Torricelli & Wilson, 2014). Keratocytes, which are mesenchymal cells with
a neural crest origin, are dispersed throughout the corneal stroma (Chan et al., 2013;
Lwigale, Cressy, & Bronner-Fraser, 2005). Keratocytes have negligible mitotic
characteristics after birth and are mostly quiescent throughout the adult lifespan.
The stroma’s primary response to injury is induction of keratocytes proximal to the
site of damage (Spurlin & Lwigale, 2013). Apoptosis of damaged cells is followed by rapid
differentiation of the quiescent keratocytes distal to damage site into active fibroblasts and
myofibroblasts (Darby, Laverdet, Bonte, & Desmouliere, 2014; Myrna, Pot, & Murphy,
2009). Uncontrolled activation of cells generate a fibrotic extracellular matrix (Petroll &
Lakshman, 2015; Torricelli, Santhanam, Wu, Singh, & Wilson, 2016), and hence, a scar is
formed. Stromal scars can take a very long time often months to completely subside due to
the quiescent nature of the embedded keratocytes (S. L. Wilson, El Haj, & Yang, 2012).

1.8.2. Corneal stromal in maintaining tissue health
The corneal epithelium consists of five layers of cells, as shown in Figure 11. They
comprise squamous cells at the top followed by 2-3 layers of polyhedral wing cells in the
middle and a single sheet of cuboidal cells at the base (Di Girolamo, 2011; Osei-Bempong,
Figueiredo, & Lako, 2013). The basal cuboidal cells are the only ones that are capable of
mitosis (Yoon, Ismail, & Sherwin, 2014). As epithelial cells turn over, the basal cells move
up by undertaking polyhedral shape and eventually move to the top until they pile up
forming the squamous layer (Haddad & Faria-e-Sousa, 2014). The tear fluid ultimately
washes these squamous cells from the surface. This typical epithelial arrangement in the
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cornea helps to refract the light at an optimum angle before it reaches the stroma and also
provides a barrier from foreign pathogens (S. L. Wilson et al., 2012). The epithelial damage
that does not impact the stroma can heal without the formation of scars (Hu et al., 2014).
When the damage to the cornea extends beyond the epithelium, the ECM rich
corneal stroma orchestrates an enhanced expression of factors to reconstruct the epithelium
and the anterior ocular surface. In the early stages of healing, stromal FN assists the newly
generated epithelial cells in binding to the injured surface (S. L. Wilson et al., 2012). In
later stages, the stroma produces collagen IV to provide permanent attachment for these
cells (Tuft G, 1993). Researchers have extensively exploited these mechanisms to design
diverse epithelial healing approaches. A faulty basement membrane is often associated
with impaired healing and re-epithelialization. The corneal basement membrane is the
interface between the stroma and the epithelium harboring a reservoir of cytokines and
growth factors (Muschler & Streuli, 2010). These molecules transmit extracellular signals
to the stromal keratocytes and induce a healing response. A highly programmed cascade of
molecular events actively regulates tissue remodeling through the expression of matrix
metalloproteinase (MMP) enzymes, and their inhibitors called tissue inhibitor of
metalloproteinases (TIMPs) (Syggelos, Aletras, Smirlaki, & Skandalis, 2013). The
damaged basement membrane is degraded by MMPs while TIMPs ensure this degradation
is limited only to the damaged region.
When the damage extends into the stroma, the responses generated are entirely
different compared to those associated with the epithelium, as illustrated in Figure 12. The
stromal keratocytes are primarily responsible for most of the generated responses. One
significant difference in stromal healing compared to epithelium repair is that all the
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processes involved are incredibly lengthy and takes months to complete (Ljubimov &
Saghizadeh, 2015; Tomas-Juan, Murueta-Goyena Larranaga, & Hanneken, 2015). The
primary reason for this is that any stromal damage can result in scar formation (Song et al.,
2016), and complete healing translates to reducing this scar and restore transparency.
Damaged keratocyte apoptosis precedes this long chain of healing responses. During this
stage, soluble mediators sourced from the epithelium cause apoptosis of the underlying
keratocytes, while distal cells get transformed into fibroblasts and myofibroblasts (Myrna
et al., 2009). Production of chemokines is increased to attract other inflammatory cells into
the stroma. These inflammatory cells are responsible for scavenging the debris of apoptotic
keratocytes (Wu & Chen, 2014).
Activated keratocytes transdifferentiate into myofibroblasts from fibroblasts under
the influence of transforming growth factor beta (TGF-β) and platelet-derived growth
factor (PDGF) (Darby et al., 2014; Forte, Della Corte, De Feo, Cerasuolo, & Cipollaro,
2010; Myrna et al., 2009). Fibroblasts are the repair phenotype of the quiescent stromal
keratocytes. Myofibroblasts produce the optimal contractile forces to compensate the
injury by causing regression of opacification or haze formation (Feng, Pi, Sriram, Schultz,
& Gibson, 2017; B. Li & Wang, 2011). However, the prolonged presence of these
myofibroblasts can result in a disorganized ECM, that can result in opacification and
scarring. After months of extensive cellular remodeling, physiological levels of the
cytokines are restored, hence hindering further fibroblast transdifferentiation and
simultaneous myofibroblast apoptosis, repopulation of the quiescent keratocytes, clearing
of fibrotic ECM and eventual restoration of stromal transparency (Du et al., 2009; Meek &
Knupp, 2015; Mittal et al., 2016).
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For a stromal ECM-based therapy to be fully functional, it needs to be nonimmunogenic and compliant with a diverse population of patients. Designing therapies that
consist of native ECM molecules in their physiological proportions could serve as a
suitable platform to supplement the injury healing microenvironment. Tissue-derived ECM
based therapies would also improve the translational chances of the regimen. While
designing a corneal prosthetic, factors desired include conduciveness to cellular growth,
transparency, and homogeneity with the surrounding tissue.
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CHAPTER 2
GENERAL METHODS

This chapter lists the common chemicals used and methods undertaken to conduct
the research presented in this thesis.

2.1. Materials
2.1.1. Cell culture
Material

Company

Catalog No.

Dulbecco’s modified
Eagle Medium-Ham’s
F-12 (DMEM/F12, 1:1)

Thermo Fischer
Scientific; Logan,
UT

SH30023.01

Fetal bovine serum
(FBS)

Atlanta Biologicals;
Lawrenceville, GA

S11095

Insulin

Sigma chemicals;
St. Louis, MO

I6634

Penicillin/Streptomycin

Thermo Fischer
Scientific; Logan,
UT

30-002-CI

Gentamycin

Sigma chemicals;
St. Louis, MO

G1397

Phosphate-buffered
saline (PBS)

Thermo Fischer
Scientific; Logan,
UT

SH30256.01

Trypsin

Thermo Fischer
Scientific; Logan,
UT

SH30236.02
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HyQTase Cell
detachment solution

Thermo Fischer
Scientific; Logan,
UT

SV30030.01

Hepatocyte growth
factor (HGF)

Millipore;
Temecula, CA

GF116

Keratinocyte growth
factor (KGF)

Millipore;
Temecula, CA

GF008

Epidermal growth

Sigma chemicals;
St. Louis, MO

E1264

factor (EGF)

2.1.2. Electrophoresis and Western blot reagents
Material

Company

Catalog No.

4-(2-hydroxyethyl)-1piperazineethanesulfonic
acid (HEPES)

Sigma chemicals;
St. Louis, MO

H3375

Triton X-100

Bio-Rad;
Hercules, CA

161-0407

Ethylene glycol-bis(βaminoethyl ether)N,N,N',N'-tetraacetic acid
(EGTA)

Sigma chemicals;
St. Louis, MO

34596

Magnesium chloride
(MgCl2)

Sigma chemicals;
St. Louis, MO

M8266

Phenylmethylsulfonyl
fluoride (PMSF)

Sigma chemicals;
St. Louis, MO

P7626

Dithiothreitol (DTT)

Bio-Rad;
Hercules, CA

161-0611

Leupeptin

Sigma chemicals;
St. Louis, MO

L-8511

Bovine serum albumin
(BSA)

Thermo Fischer
Scientific; Logan,
UT

BP1605-100
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Protein assay dye reagent

Bio-Rad;
Hercules, CA

500-0006

Sodium dodecyl sulfate
(SDS)

Bio-Rad;
Hercules, CA

161-0302

Tris base

Fischer Scientific;
Pittsburgh, PA

BP151-1

Glycerol

Acros Organics;
New Jersey, NJ

277360010

Beta mercaptoethanol

Bio-Rad;
Hercules, CA

161-0710

Bromophenol blue

Amresco; Solon,
OH

0449

Glycine

Bio-Rad;
Hercules, CA

161-0724

Acrylamide

Bio-Rad;
Hercules, CA

161-0158

Ammonium persulfate
(APS)

Bio-Rad;
Hercules, CA

161-0700

Tetramethylethylenediamine Bio-Rad;
(TEMED)
Hercules, CA

161-0800

Methanol

Fischer Scientific;
Pittsburgh, PA

A452-4

Sodium chloride (NaCl)

Fischer Scientific;
Pittsburgh, PA

S271-3

Blotting grade nonfat dry
milk

Bio-Rad;
Hercules, CA

170-6404

Tween 20

Sigma chemicals;
St. Louis, MO

P5927

ECL Prime Western blotting Amersham;
reagent
Arlington Heights,
IL

RPN2236
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Coomassie Brilliant blue
R-250 dye

Thermo Fischer
Scientific; Logan,
UT

20278

2.1.3. Cell proliferation and glucose assay kits
Material

Company

Catalog No.

CytQuant assay kit
(Kit includes CytQuant
cell lysis buffer + GR
dye)

Molecular Probes;
Grand Island, NY

7026

Glucose assay kit
(Kit includes assay
solution + Glucose
standard)

Eton Biosciences;
San Diego, CA

1200031002

Material

Company

Catalog No.

Prestained SDS-PAGE
Precision Plus standard

Bio-Rad;
Hercules, CA

161-0373

Biotinylated protein
ladder

Cell Signaling;
Danvers, MA

7727

Material

Company

Catalog No.

Anti-collagen I mouse
monoclonal antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-59772

2.1.4. Protein markers

2.1.5. Primary antibodies
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Anti-collagen IV mouse
monoclonal antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-52317

Anti-fibronectin mouse
monoclonal antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-73611

Anti-cyclin A rabbit
polyclonal antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-751

Anti-cyclin D1 rabbit
polyclonal antibody

Cell Signaling;
Danvers, MA

2978S

Anti-cdc42 rabbit
polyclonal antibody

Millipore;
Temecula, CA

07-896

Anti-CDK4 rabbit
polyclonal antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-260

Anti-CDK2 rabbit
polyclonal antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-748

Anti-Cyclin E rabbit
polyclonal antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-247

Anti-p21cip rabbit
polyclonal antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-756

Anti-p27kip mouse
monoclonal antibody

Millipore;
Temecula, CA

610242

Anti-phospho-Akt1/PKB
mouse monoclonal
antibody

Millipore;
Temecula, CA

05-669

Anti-phospho-ERK
mouse monoclonal
antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-7383
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Anti-beta-actin mouse
monoclonal antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-47778

Anti-cytokeratin 3 mouse
monoclonal antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-80000

Material

Company

Catalog No.

HRP linked goat antimouse secondary
antibody

BD Pharmingen;
San Diego, CA

554002

HRP linked goat antirabbit secondary
antibody

BD Pharmingen;
San Diego, CA

554021

FITC linked-anti-mouse
secondary antibody

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-516140

HRP linked goat antibiotin secondary
antibody

Cell Signaling;
Danvers, MA

7075

Material

Company

Catalog No.

Collagenase type I

Worthington
Corporation;
Lakewood, NJ

LS004194

Collagenase type IV

Sigma-Aldrich;
St. Louis, MO

C5138

2.1.6. Secondary antibodies

2.1.7. Collagenase enzymes
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2.1.8. Miscellaneous
Material

Company

Catalog No.

Sodium hydroxide
(NaOH)

Fischer Scientific;
Pittsburgh, PA

S318-1

Glutaraldehyde 25%
solution

Santa Cruz
Biotechnology;
Santa Cruz, CA

Sc-300764

2.2. Methods
2.2.1. Preparation of corneal tissues for cell culture
Fresh adult human and porcine corneas were used to prepare corneal epithelial
primary cultures in different experiments. Adult human corneas were obtained from
Dakota Lions Sight & Health (Sioux Falls, SD). Donor age for these corneas ranged from
39 to 79 years (mean, 59 years) and distribution of the donors according to sex was 60%
male and 40% female. The time from the death of the patient to enucleation varied from 3
to 5 hours. All corneas were supplied and preserved in Optisol solution at 4°C.
Eye globes from farm-grown pigs (Sus crofa domesticus) were procured from three
different sources – (a) Bob’s Custom Meats (Chester, SD)- a local slaughterhouse, (b) from
John Morrell & Co. (Sioux Falls, SD) and the South Dakota State University Veterinary
Science Department (Brookings, SD). The eyeballs were enucleated within 10-20 minutes
of death, and tissues were shipped to the laboratory on ice in sterile PBS. All animals were
raised for six to eight months of age, and they weighed 280-300 lbs. Breed diversity of the
animals were 70% white (not albino) and 30% colored. All eye globes were harvested
within 3 hours of sacrificing the animals.
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2.2.2. Corneal epithelial cell culture
Corneas were deendothelialized by scraping the endothelial layer with a surgical #
11 blade and then washed for at least three times in sterile serum-free DMEM/F12 medium
and incubated with the epithelial surface exposed to 5 ml of HyQTase cell detachment
solution for 1 hour at 370C. Following incubation, the epithelial cells were scraped off from
the surface using a new cell scraper. The isolated cells were suspended in complete medium
(DMEM-F12 medium supplemented with 10ng/ml EGF, 25 µg/ml insulin, and 10 % FBS)
and seeded in T-25 flasks. The medium was changed two times in three weeks. After the
cultures reached 80-90% confluence, cells were treated with 0.05% trypsin for 10 minutes
at 370C, centrifuged at 2500 rpm for 10 minutes and plated on to six-well tissue culture
dishes (50,000-100,000 cells/well) in 2 ml/well complete medium. After first passage cells
attained 70-80% confluence, they were passed again, second or third passaged cells were
used in all experiments.

2.2.3. Corneal fibroblast culture
Deepithelialized and deendothelialized corneas were cut into small buttons using
scissors and treated with HyQTase cell detachment solution for 6-8 hours at 370C (Figure
13). After completion of HyQTase treatment, cornea buttons were washed for at least five
times with serum-free DMEM/F12 medium to remove the cell detachment solution.
Washed cornea buttons were then placed in 60-mm tissue culture dishes (about 15
buttons/dish) carefully ensuring they were distributed throughout the dish. Approximately
100-300 µl of DMEM/F12 medium supplemented with 10% FBS was added dropwise
around the perimeter of each button to ensure that they do not dry out during the incubation

30

process. Buttons were incubated in 370C for at least 12 hours. Following incubation, cornea
buttons were removed, and the medium was replaced with 8-10 ml of DMEM/F12
medium/60-mm dish supplemented with 10% FBS.

2.2.4. Preparation of cell lysate
Cells harvested from different experiments were washed at least three times with
ice-cold PBS and extracted in freshly prepared lysis buffer (20 mM HEPES, 2 mM MgCl2,
2mM EGTA, 2mM sodium orthovanadate, 2mM DTT, 1mM PMSF, 0.1 mM leupeptin,
0.15 mM NaCl). After exposure to lysis buffer, cellular extracts were homogenized using
a hand-held homogenizer and centrifuged at 14000 rpm for 25 minutes at 4oC. The
supernatant was collected, and the protein content of lysates was evaluated using Bio-Rad
protein assay reagent and all lysates were stored at -20oC until further use.

2.2.5. Protein estimation
Protein content of cell lysates was determined by using the Bio-Rad protein assay
dye in a 1ml cuvette. The dye reagent was first diluted (1:4), that is, 1-part dye concentrate
diluted with 4-parts of deionized water. Bovine serum albumin (BSA) was used as a
standard, and three to five dilutions of the standard were made (0 to 6 µg). Blank samples
(0 µg/ml) was made using water and dye reagent, respectively. The assay was performed
in duplicates or triplicates. Absorbance was measured at 595 nm.
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2.2.6. SDS-PAGE and Western Immunoblotting
2.2.6.1. Electrophoresis
Cellular extracts (approximately 10-20 µg protein for cell cycle experiments, 1-10
µg for stromal extracts and 10-30 µl volume for conditioned medium samples) were
subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in
7-15% gels using Bio-Rad Mini-Protean II electrophoresis unit. Resolving and stacking gel
solutions were allowed to polymerize for 20 minutes between the glass plates. While the
gels were left to polymerize, the top of the gels was covered using 50% isopropanol, 0.1%
SDS solution or distilled water. Stacking gels were added later to a height of 1 cm with a
pipette to avoid bubble formation. The stacking gels were allowed to polymerize for at
least 20 minutes and transferred to the electrophoresis tank in the presence of 1X electrode
buffer (Tris-HCl 25mM, glycine 200 mM, 0.1% w/v SDS). Protein markers were loaded
last. Electrophoresis was run at an appropriate voltage and current until the dye front
reached the gel bottom.

2.2.6.2. Western Immunoblotting
The gels and nitrocellulose membranes were equilibrated in transfer buffer (25 mM
Tris, 192 mM glycine, 20% v/v methanol 1 liter) for 10 minutes before the transfer process.
The transfer sandwich was constructed in the following sequence: transparent sandwich
holder, sponge pad, filter paper, gel, nitrocellulose membrane, filter paper, blotting pad,
black sandwich holder. A pipette or test tube was used to roll on the filter paper to avoid
the formation of air bubbles. Protein transfer from the gel to nitrocellulose membrane was
carried out at 100V for 2 hours.
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Each antibody used in this study was diluted according to the experimental
requirement. The membranes containing transferred proteins were blocked with 5% nonfat
dry milk in TBS (20 mM Tris-HCl [pH 7.4], 0.05% Tween-20). The membranes were
washed six times at 10-minute intervals, with TBS containing 0.05% Tween-20 and then
probed with primary antibodies as specified in each experiment for 3 hours at room
temperature or overnight at 4oC. The membranes were again washed six times at 10-minute
intervals with TBS and 0.05% Tween 20 and then incubated with species-specific HRPconjugated secondary antibodies. The membranes were then treated with enhanced
chemiluminescence ECL reagent. Gel and Blot images were imaged using the BioRad GelDoc XR Documentation system. The desired protein bands of interest were identified and
quantified using ImageLab software from BioRad. Molecular weights were determined by
comparing with the mobility of biotinylated protein markers that were run simultaneously
during electrophoresis.

2.2.7. CytQuant cell proliferation assay
Porcine corneal epithelial cells, dispersed in serum-free DMEM/F12 medium, were
seeded in a 96-well plate at a density of 5000-10000 cells/well (100-200 µl/well) and
incubated overnight at 370C. The following day, wells were washed with sterile PBS to
remove unadhered cells and treated with different samples, as indicated in the chapters
later. At the end of each experiment, cells were washed with PBS, and culture plates were
frozen at -800C until further analysis. The plates were thawed, and the DNA content of
cells in each well was quantified using the CytQuant proliferation assay kit. In the presence
of the fluorescent CytQuant GR dye, strong fluorescence was exhibited when bound to
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DNA, and the detection was performed at an excitation wavelength of 480 nm and an
emission wavelength of 520 nm.

2.2.8. Ex-vivo organ culture studies using of intact eye globes
Porcine or human cornea surface was de-epithelialized using a No. 15 scalpel blade
under sterile conditions prior to organ culture of the cornea. The cornea surface was gently
dabbed with a sterile Kim wipe throughout this process to ensure any loosely attached
epithelium was removed. Following this, a rectangularly shaped incision was performed
on the de-epithelialized cornea using No. 11 scalpel blade such that a flat cornea button
could be excavated from the eye globe (Figure 15). These excised cornea buttons were
washed at least three times with sterile PBS and placed endothelial-side down into a sterile
60 mm dish. De-epithelialized surface of the corneal button was treated with cell
suspensions, conditioned medium collected from cornea ex-vivo experiments (COCM), or
ECM, or serum-free DMEM/F12 medium as required in different experiments. Serum-free
DMEM/F12 culture medium (about 0.5 ml) was added dropwise surrounding this button
to maintain tissue integrity yet ensuring to leave the epithelial surface exposed to the air.
Cornea buttons were incubated for 4-48 hours at 370C. After completion of the study
period, buttons were washed three times with sterile PBS to remove any loosely attached
cells and then imaged under the microscope for epithelial regeneration. The quantification
of re-epithelialized areas was performed by image analysis (ImageJ 1.44 software).

34

2.9. Scanning electron microscopy (SEM) studies
All samples for SEM analysis were subjected to gradual cooling (starting with 200C for 3 hours then gradually advancing to -800C for 8 hours). After the samples were
completely frozen, they were subjected to lyophilization for 48 hours at about -105°C/100
mTorr vacuum. Freeze-dried sample surfaces were then sputter-coated with a layer of ~10
nm gold film before imaging by a scanning electron microscope (SEM). SEM images were
acquired using a Hitachi Scanning Electron Microscope with an Energy Dispersive X-ray
analysis at different magnifications.

2.2.10. Optical properties
Transparency of samples was evaluated in terms of absorbance in the visible range
using a Multiscan Spectrum (Molecular Devices). Prepared samples were scanned from
400 to 700 nm wavelength range with 50 nm intervals. The transparency was calculated
as a percentage of transmittance using Beer’s law, A=2-log100%T, (where A: absorbance
and T: transmittance). Cornea control values were taken from established literature.
The refractive indices of samples were determined using an Abbe’s refractometer
with standard monochromatic light at a wavelength of 589 nm. Cornea control refractive
indices (RI) were taken from established literature. Glycerol was used as a positive control
for both transmittance and RI determined experiments.

2.2.11. Rheological (viscosity and viscoelastic) properties
Rheological experiments were performed on an AR-2000 rheometer (TA
Instruments) using a 40 mm-diameter para llel plate geometry tool. Samples were stored
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in ice at 40C to minimize the possibility of thermal gelation. A measured amount of sample
(~5 ml) was transferred to the rheometer bottom base plate that was pre-equilibrated at
250C. The geometry tool was then lowered to a gap height of 300 mm to delay edge effects.
Excess sample solution outside the perimeter of the geometry tool was trimmed using a
flat-ended spatula. This step was conducted to ensure that the extent of filling was within
acceptable conditions. First, the dynamic viscosity of ECMIX was evaluated at shear rates
ranging from 0.01 to 1 s-1 at 250C. Then, the viscoelasticity of samples was assessed by
performing a frequency sweep between 0 to 70 rad/s at a constant stress of 0.79 Pa.

2.2.12. Swelling/hydration measurements
Scaffolds were placed in a 1.5 ml tube and suspended in 1 ml of distilled water at
250C. The wet weight of samples was determined on an analytical balance at variable time
points, after carefully blotting them free of surface moisture using filter paper. After each
time point, samples were returned to the swelling medium. The swelling ratio was
determined from the equation,
Swelling ratio = Swollen weight of the construct (Ws) - Dry weight of the construct (Wd)
The dry weight of the construct (Wd)
The ratio of the weight of water in the sample to the weight of the sample at
equilibrium hydration, expressed as a percentage, for each time point studied.

2.2.13. Glucose permeation properties
Glucose permeability of samples was evaluated using a Franz diffusion setup
(PermeGear, Inc., PA). The glucose concentrations of solutions in each of the chambers
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were periodically measured using a Glucose assay kit. This assay is based on the enzymatic
conversion of glucose to glucose-6-phosphate, followed by the production of dinucleotide
and quantified UV absorption.
The setup was equilibrated at 340C before the start of each experiment, and the
conditions were maintained by circulating warm water. Scaffold were placed between the
donor and receptor chambers of the diffusion cell. Serum-free high-glucose DMEM
solution containing 3mM glucose and PBS were used as the donor and receptor medium,
respectively. Donor chamber was loaded media solution. Samples were collected from the
receptor compartment after 6 hours, which was replaced with an equal volume of fresh
PBS.
The permeability coefficient of glucose was calculated from the rate of glucose
concentration change with time. Intact corneas were used as controls where the corneal
endothelial and epithelial side faced the donor and receptor chambers, respectively.
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CHAPTER 3
RELEASE OF EXTRACELLULAR MATRIX PROTEINS FROM CORNEA IN
RESPONSE TO INJURY: ITS RELEVANCE TO EPITHELIAL REGENERATION

3.1. Introduction
The cornea consists of a 400-500 µm thick stroma that is composed of ECM
proteins. The ECM of stroma undergoes synthesis, degradation, and remodeling of its
components (Malandrino, Mak, Kamm, & Moeendarbary, 2018). This is required not only
to maintain correct mechanical function under physiological conditions but also in response
to damage/injury (Torricelli & Wilson, 2014). The turnover of ECM is regulated by the
concurrent expression of collagenases and hyaluronidases (Torricelli et al., 2016; Torricelli
& Wilson, 2014).
In the adult human cornea, stromal collagens account for 80% of the total ECM.
The majority of ECM synthesis occurs during the embryonic stage (Dyrlund et al., 2012;
Hassell & Birk, 2010; Michelacci, 2003). However, a low-level of collagen polypeptide
synthesis continues throughout adult life (Schwarz, 2015). A certain number of matrixdegrading proteases are also expressed throughout life. Other ECM constituents like
hyaluronan and laminin molecules undergo more frequent and faster turnover rates than
the collagenous proteins (Kim, Turnbull, & Guimond, 2011; Rozario & DeSimone, 2010).
As the cornea’s primary function is to refract light, dynamic remodeling of the stromal
ECM is necessary for the maintenance of transparency. Excessive or uncontrolled
remodeling is considered a factor in a variety of disease states (Zhou, Cao, Wu, & Zhang,
2017).
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It has been reported that in several tissues during stromal remodeling, ECM
undergoes proteolytic processing that results in the release of matrix fragments (Chen et
al., 2015; Malik, Lelkes, & Cukierman, 2015), called as matrikines (Maquart, Pasco,
Ramont, Hornebeck, & Monboisse, 2004). Matrikines promote cellular infiltration and
wound healing (Gaur, Dobke, & Lunyak, 2017; D. F. Patel & Snelgrove, 2018; Arroyo &
Iruela-Arispe, 2010; Frangogiannis, 2017). Matrikines collectively influence stromal cell
signaling and trafficking of ECM components to localized tissue spaces. Signals generated
from the matrikines are similar to the parent matrix components from which they are
derived. For example, degraded components of collagen and elastin induce leukocyte
activation and migration (Xu & Shi, 2014). Similarly, the degradation products of basement
membrane constituents like collagen IV and laminin act as signal mediators that target the
epithelium (Tanner, 2012).
Researchers have shown that ECM proteins have a significantly positive influence
on the upregulation of cell cycle activity in mammalian tissues (Moreno-Layseca & Streuli,
2014). Previous studies from our laboratory have shown that ECM proteins upregulate the
expression of cell cycle proteins in corneal epithelial cells (Chandrasekher & Pothula,
ARVO Annual Meeting Abstract, 2014). We hypothesize that matrikines generated from
stromal ECM could influence corneal epithelial regeneration. Stromal response to
epithelial injury consists of an active phase that involves the effect of various ECM proteins
that promote healing, and it takes place throughout six months after injury, and a
remodeling phase to regain transparency that takes up to 3 years (Betensley, Sharif, &
Karamichos, 2016). While growth factors and cytokines are integral components that could
mediate the connection between stroma and epithelium to promote healing, ECM protein
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influence is also critical for the epithelial wound healing process (Olczyk, Mencner, &
Komosinska-Vassev, 2014).
ECM proteins support cell adhesion, migration, and proliferation through a cascade
of complex mechanisms. Corneal epithelial injury has been shown to significantly engage
the ECM components for accelerated healing (Carrier et al., 2008; Ljubimov &
Saghizadeh, 2015). The primary function of corneal stromal keratocytes is to maintain
steady homeostasis of the stromal extracellular matrix components. When an epithelial
injury where the damage extends to the basement membrane and stroma occurs like that
originating from penetrating keratectomy or alkali damage, keratocytes are activated and
initiate a healing response (Torricelli et al., 2016). The activated keratocytes migrate to the
site of injury. These activated cells start generating new ECM components as required to
compensate for the damage caused due to injury (S. E. Wilson et al., 2017). A clear
understanding of ECM degradation and remodeling could lead to the development of
improved ECM based therapeutic systems for epithelial as well as stromal wound repair.
Studies described in this chapter identify the release of different ECM proteins and
the pattern of their release following an injury to the corneal epithelium. A basis for the
release of these ECM proteins is explored. Further, a possible role for the released proteins
in promoting epithelial wound healing is investigated.
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3.2. Methods
All general methods are described in Chapter 2, and specific methods relevant to
the experiments described in this chapter are included below.
3.2.1. Cornea ex-vivo organ culture
Corneas were subjected to mechanical injury by epithelial debridement and
maintained in serum-free DMEM/F12 medium (1ml/cornea) at 370C for 0-60 hours (Figure
14). Four corneas were employed for each experimental condition. The medium in which
the corneas were incubated was referred to as COCM (cornea organ cultured conditioned
medium) throughout this thesis. At different time points of incubation, COCM was
collected. The medium collected at each time point from multiple corneas was pooled and
subjected to centrifugation at 4000 rpm for 10 minutes to remove cellular debris. Incubated
corneas were replenished with fresh medium after each time point collection. Samples
collected from uninjured corneas incubated under similar organ culture conditions served
as controls. The detailed experimental protocol is presented in Chapter 2.

3.2.2. Identification of ECM proteins in COCM by SDS-PAGE/Western immunoblotting
COCM samples were subjected to SDS-PAGE and Western immunoblotting as
described earlier in Chapter 2. Polyacrylamide gels (6-7%) were used in these studies. Blots
were probed with anti-collagen I, anti-collagen IV and anti-fibronectin primary antibodies,
and species-specific secondary antibodies conjugated with HRP respectively, as indicated
in the results.
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3.2.3. Digestibility of ECM proteins in COCM by collagenase
To evaluate the collagenous nature of the secreted peptides, COCM collected from
injured corneas were subjected to collagenase treatment. COCM (80µl) from each
experimental condition was treated with five units/mg of collagenase type I and IV at 370C
for 1 hour. COCM samples incubated under similar conditions in the absence of
collagenase were used as controls. After the completion of incubation, 20 µL of 4X
electrophoresis sample buffer containing mercaptoethanol was added to the mixture and
samples were heated at 1000C for 5 minutes and subjected to gel electrophoresis and
western immunoblotting.

3.2.4. Effect of COCM on epithelial cell regeneration
(a) To evaluate the cell regeneration capabilities of ECM components in COCM,
cells were treated with COCM samples collected at various time points. Cultured primary
epithelial cells were exposed to 200ul of COCM at 370C in tissue culture incubator for 24
hours. CytQuant Assay was performed to determine the changes in DNA levels that
represent the levels of cell growth, as described in Chapter 2.
(b) Additionally, the de-epithelialized human corneal surface was exposed to
COCM containing HCEC/PCECs. Corneas were incubated under organ-culture conditions,
as described in Chapter 2. Cultured primary HCEC or PCEC (25000-30000 cells)
suspended in COCM (5-10 µl) collected from different experiments were placed on the
surface of the cornea button. Cells suspended in DMEM/F12 were used as control samples.
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3.2.5. Statistical Analysis
Statistical data represented as the mean ± SD and analyzed using Student’s t-test or
ANOVA; p < 0.05 was considered statistically significant.

3.3. Results
3.3.1. Enhanced release of ECM proteins from the cornea after epithelial injury
Presence of different ECM proteins was observed in organ culture medium in which
corneas were incubated (Figure 16). Three of the proteins as identified by western
immunoblotting using specific antibodies are collagen I (~140 kDa and ~75 kDa, Figure
16A), fibronectin (250 kDa, Figure 16B) and collagen IV (~140 kDa, Figure 16C).
Interestingly, there was an increased release of these proteins from injured corneas, and the
levels of the released proteins were significantly higher as compared to controls.

3.3.2. Collagenous nature of the ECM proteins released into COCM
Collagenase treatment of COCM samples containing various released ECM
peptides resulted in the disappearance of both 140 and 75 kDa bands collagen type I and
the 140 kDa band in collagen type IV indicating the collagenous nature of the released
proteins.
Loss of protein bands in both injured and uninjured COCM samples following
collagenase treatment was noted after Coomassie blue staining of SDS/PAGE gels (Figure
17A). Some protein bands remained after collagenase treatment indicating all the
components in the sample were not collagenous. The disappearance of secreted collagen
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type I and collagen type IV peptides after collagenase treatment was also confirmed by
immunoblotting (Figure 17B).

3.3.3. Secretion Kinetics of Collagen I, Collagen IV and Fibronectin release following
corneal epithelial injury
In this study, the release pattern of various ECM proteins as a function of time was
evaluated. For this purpose, both control and epithelium debrided corneas were incubated
in organ culture for a period up to 60 hours, and COCM was collected periodically (4, 8,
24, 48, and 60 hours). Samples of COCM were analyzed for the changes in the levels of
different ECM proteins. The released amount of all identified ECM proteins from injured
corneas, (Col I-Figure 18A, Col IV-Figure 18B, and FN-Figure 18C) was significantly
higher compared to control corneas at all studied time points.
The 0-60-hour release profile for Col IV and FN peptides from injured corneas was
comparable to control corneas (Figure 19 C and Figure 19 D). Interestingly, the release
pattern of Col I polypeptides was different when compared to controls. Significantly higher
amounts of 140 kDa (Figure 19 A) and 75 kDa (Figure 19 B) peptides were released from
injured corneas during the initial 0-8-hour period and then decreased gradually. However,
Col I secretion level in control cornea remained mostly unchanged throughout the study
period.
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3.3.4. The molecular size of released ECM proteins is similar to corneal stromal
extracellular matrix components
Corneal stromal ECM proteins are subjected to degradation and remodeling as a
consequence of damage/injury. It is possible that ECM polypeptides identified in COCM
could have originated from stromal matrix components. To ascertain this, we have
compared the molecular sizes of released proteins with that of stromal matrix components.
For this, corneal stromal proteins were extracted in an aqueous solvent (described in
Chapter 4). Extracted proteins were subjected to Western immunoblotting and identified
protein molecular size profile was compared with that of COCM released ECM
polypeptides. As compared to two Col I polypeptides that were identified in COCM (75
and 140 kDa), stromal matrix contained three different polypeptides of molecular weight
250, 140 and 75 kDa. Similarly, Col IV of stromal matrix contained a high molecular
weight 250 kDa peptide which was absent in collagen IV of COCM. Interestingly, the
molecular size of fibronectin protein present in the stromal matrix was 100 kDa, while the
fibronectin polypeptide released into COCM showed a molecular weight of 250 kDa.

3.3.5. Evaluation of corneal stromal ECM protein degrading capability of COCM
In this study, the hypothesis that MMPs expressed in stroma act on stromal matrix
proteins leading to the release of degraded matrix polypeptides identified in COCM is
tested. For this, COCM that could contain MMP activity was treated with stromal extract
comprising different ECM components and polypeptide profile before and after treatment
with COCM was compared. As shown in figure 20 stromal ECM protein profile remained
unchanged after treatment with COCM indicating that COCM lacked the proteolytic
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activity, or the activity is blocked due to the presence of MMP inhibitors (TIMPs) which
are expressed to regulate MMP action (Lluri, J. & Jaworski, D.M., 2005) and concurrently
released into the same medium. The other possibility is that the stromal proteins are not
susceptible to proteolytic degradation under the experimental conditions described in this
study.
3.3.6. COCM promotes epithelial cell proliferation
COCM collected from injured corneas at different time points showed epithelial
growth promoting potential (Figure 21). A 40-50% increase in epithelial cell proliferation
in the presence of COCM was observed compared to control cells grown in the absence of
COCM.

3.3.7. COCM promoted epithelial cell attachment and regeneration on the epithelial
debrided human cornea surface
Cultured HCECs suspended in COCM collected at 4 or 24 hours time point attached
to de-epithelialized human cornea surface and grew rapidly. As shown in figure 22, the
propagation of epithelial cells suspended in DMEM/F12 medium (controls) on the denuded
surface is also evident. Presence of COCM produced a very robust growth pattern, and cell
sheet formation is more organized compared to controls. There were very few uncovered
areas on the corneal surface when COCM was employed, for epithelial regeneration.

3.4. Discussion
This work identified the release of different ECM proteins (collagen I, collagen IV
and fibronectin) from corneas incubated in organ-culture conditions. Presence of these
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ECM peptides in COCM from both control (uninjured) and de-epithelialized corneas
suggests that the stroma of the cornea is the primary site from which they are produced.
Presence of ECM peptides in COCM of control corneas indicates that these peptides are
also generated under physiological conditions, albeit in very low levels.
Levels of ECM proteins released from injured corneas is significantly higher than
that observed with unwounded corneas. Injury to the cornea induces the activity of the
stromal keratocytes (Stramer, Zieske, Jung, Austin, & Fini, 2003). Keratocyte activity
could trigger the cellular mechanisms that upregulate the expression of matrix proteins that
are secreted out of the cells to rebuild the stromal matrix (Funderburgh, Mann, &
Funderburgh, 2008). The molecular weight of collagen I and IV peptides identified in
COCM is similar to those collagens that constitute the stromal matrix, except that stroma
contained a high molecular weight 250 kDa peptide species.
Expression of matrix metalloproteinases (MMPs) is known to upregulate in corneal
stroma after tissue damage. MMPs play a significant role in ECM protein degradation and
remodeling. It is possible that released peptides are breakdown products of stromal
collagens generated by the action of MMP as reflected by the several-fold increase in levels
of polypeptides when the cornea is injured. However, this study did not establish the
possibility that stromal high molecular weight collagen peptides (250 kDa) are MMP
substrates and precursors for released fragments (140 and 75 kDa) found in COCM.
Alternately, the released peptides are generated under physiological conditions by
keratocytes to maintain stromal ECM homeostasis. In that regard, it is important to note
that control unwounded corneas also released peptides in COCM. Stromal keratocyte
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activation in response to injury accelerates their generation as evidenced by the presence
of significantly higher levels of released peptides in COCM of the injured corneas.
While the reason why the ECM proteins are released from corneas is not clear, we
found that COCM containing Col I, IV and fibronectin possessed significant potential for
promoting cellular growth. Exposure of epithelial cells to COCM increased cell
proliferation. Further, epithelial cells suspended in COCM adhered to the denuded corneal
surface and formed a very well-organized epithelial sheet similar to that observed in native
cornea indicating the importance of ECM component present in COCM for cell
regeneration and wound healing. Increased levels of their release from injured corneas
support the view that their presence could play a critical role in promoting wound healing
that involves the regeneration of the epithelium. The ECM peptides released from
uninjured corneas may be needed to promote the cell proliferation to restore the loss of
epithelial cells due to normal turnover. Further studies are needed to investigate the
mechanism of action of these peptides in promoting growth. Nevertheless, employment of
a mixture of ECM proteins released from native corneal tissue could have therapeutic
utility in multiple corneal dystrophies.
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CHAPTER 4
CORNEA ECMIX: A NOVEL TISSUE-DERIVED BIOMATERIAL - ITS
DEVELOPMENT, CHARACTERIZATION AND CLINICAL APPLICATIONS

4.1. Introduction
Two-third of the eye’s refractive power is accounted for by the cornea and
maintaining its health is critical for proper vision (Meek & Knupp, 2015). Epithelial cell
layer on the corneal surface along with the stroma contribute to its refractive property
(Torricelli, Singh, Santhiago, & Wilson, 2013). The cornea is susceptible to damage
through both injury and disease. In many clinical conditions such as dry eye and other
anterior corneal dystrophies, erosion of epithelial cells is recurrent and corneal surface
often fails to heal quickly (Nishida, Inui, & Nomizu, 2015). Epithelial healing is also
significantly impaired if the cornea is damaged due to harsh chemical and mechanical
injuries (Evans, Oreffo, Healy, Thurner, & Man, 2013). A delay in the replacement of
eroded corneal epithelium leads to the development of scarring/haze that can interfere with
its refractive function. Abnormality in basement membrane structure or impairment in
epithelial regeneration contribute to infective wound healing (Torricelli, A.A., Singh, V.,
Santhiago, M.R., & Wilson, S., 2013).
The most common corneal epithelial disorder is recurrent corneal erosion syndrome
(RCES) (Laibson, 2010). RCES is characterized by two significant clinical abnormalities
– (a) damaged basement membrane and (b) deficiency of limbal stem cells (which
differentiate to generate epithelium) (Myrna et al., 2009). RCES can result from external
injuries/trauma, epithelial basement membrane dystrophy (EBMD), or a combination of
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these factors (Das & Seitz, 2008; Mort et al., 2012). Patients with EBMD have an anterior
epithelium that does not adhere well to the basement membrane. An abnormal composition
or formation of the basement membrane prevents the successful attachment of freshly
generated cells hindering healthy cell growth (Laibson, 2010; Torricelli et al., 2013). A
loose epithelium can also affect the underlying stroma leading to disruptions in corneal
clarity and cause pain (Laibson, 2010). In limbal stem cell deficiency, a lack of
differentiation of limbal stem cells into the epithelium eventually results in inadequate
number of new epithelial cells needed to replenish the cell loss due to trauma or disease.
After the epithelial injury, the stromal keratocytes posterior to the damaged site undergo
apoptosis. Keratocytes distal to the injury site get activated and differentiated into corneal
fibroblasts and myofibroblasts, leading to the production of ECM proteins. This follows
the initiation of epithelial healing processes to repair the wound.
The corneal basement membrane and stroma are located directly posterior to the
epithelium and play a pivotal role in the epithelial healing process (Lee, Lee, Lee, & Choi,
2013). Fibronectin and collagen IV are necessary for the formation of the basement
membrane and promote cell adhesion and migration. Collagens are the most abundant
ECM proteins in the stroma (Dyrlund et al., 2012). The fibril-forming collagens are types
I, II, III, V, VI, and XI [17]. Nonfibrillar collagens (types XIII, XVII, and XXV (Gordon
& Hahn, 2010) are also reported to be present in the cornea. Stromal ECM also comprises
many proteoglycans (e.g., mucopolysaccharides). ECM proteins and proteoglycans in the
corneal stroma assist in coordinating an organized healing response to any forms of
damage.
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Currently, available therapies such as antibiotics and anti-inflammatory steroid eye
drops/ointments and eye patches are merely targeted to eliminate pain (Palioura, Henry,
Amescua, & Alfonso, 2016). These therapies reduce the friction on the corneal surface and
the spread of infection but have a minimal impact on cell regeneration (Thomas, 2003).
Therefore, development of an effective therapeutic system that promotes cell regeneration
is the need of the hour.
Developed strategies to regenerate epithelium on injured cornea include drops of
growth factor or collagen shields coated with growth factor, and scaffolds of amniotic
membrane whose composition is similar to the basement membrane. None of these
products yielded desired results in improving the epithelial wound healing. Therefore,
development of an effective therapeutic system that promotes epithelial regeneration and
enhances healing is necessary. As described in chapter 3, in response to injury, cornea
released multiple ECM proteins. Further employment of a mixture of released proteins
promoted epithelial cell proliferation in cultures and enhanced epithelial sheet regeneration
on corneas devoid of the epithelium in ex vivo conditions. Furthermore, Col I, one of the
proteins that are identified among the cornea released proteins is a major constituent of
stromal ECM. These findings imply that ECM components native to the cornea are better
suited for therapeutic purposes. Development of a method to isolate entire corneal
extracellular matrix composition, which is designated as cornea ECMIX is described in
this chapter. Experiments related to ECMIX characterization and biological functions are
also presented in this chapter.
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4.2. Methods
4.2.1. Preparation of corneal extracellular matrix mixture (ECMIX)
The preparation scheme of ECMIX is illustrated in Figure 24. Porcine corneas were
de-epithelialized using a scalpel attached to number 15 surgical blade. Corneas were rinsed
with sterile PBS and gently blotted with Kim-wipes repeatedly to ensure removal of the
loosely attached epithelium. De-epithelialized corneas were then dissected from the
eyeballs using a scalpel attached with number 11 surgical blade. First, the corneas were
extracted with 1.23 ml/cornea volume of 1N sodium hydroxide for 4-6 days. During this
stage, extraction setup was stirred continuously at 40C. Changes to the corneas being
extracted were monitored. After 4-6 days, the preparation appeared highly viscous, and
most corneas became inflated but stayed intact. After the corneas were inflated, 1.14
ml/cornea volume of fresh 1 (N) sodium hydroxide was added to the extraction setup. At
this point, the total sodium hydroxide in the setup accounted for a volume of 2.37
ml/cornea. The setup was maintained in 40C, and it was routinely evaluated whether the
corneas had dissolved into a complete liquid solution. The corneas were dissolved entirely
after about 16 days. After the extraction was complete, dissolved cornea solution (20 ml)
was dialyzed against 2.5 liters 15-mM HEPES buffer solution (pH 7.5) for 24 hours.
Further, the cornea liquid solution dialysis was continued for another 24 hours against 2.5
liters serum-free DMEM/F12 medium or a fresh setup of 2.5 liters 15-mM HEPES buffer
solution. At the end of this step, dissolved cornea solution pH was adjusted to a
physiological value (e.g., about pH 7.4). Dialyzed cornea extract was centrifuged for 20
minutes at 14000 rpm to remove any particulate material generated during the extraction
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or dialysis process. Following this, the centrifuged supernatant was sterilized under UV
light for 6 to 8 hours. Prepared ECMIX solution was stored until further use.

4.2.2. Identification of ECMIX components
ECMIX (2–30 μg protein) was suspended in electrophoresis buffer and subjected
to SDS-PAGE electrophoresis in 7% gels followed by western immunoblotting, and
transferred proteins were probed with specific antibodies as indicated in the results for the
identification of ECMIX components.

4.2.3 Scanning Electron Microscopy (SEM) analysis
Fibrillar network organization was analyzed of ECMIX by scanning electron
microscopy.

4.2.4. Effect of ECMIX on corneal epithelial ERK and PI3-K/Akt activation
Cultured PCECs at 60% to 70% confluence were starved overnight in DMEM/F12
with 0.25% FBS. Starved cells were then treated with ECMIX 144 µg/mL for 5, 10- and
20-minutes duration. Cells treated for 10 minutes with hepatocyte growth factor (HGF, 10
ng/mL), a known stimulator of ERK and Akt (Nakagami et al., 2001), was used as a
positive control. Untreated PCECs were used as a control group. Following treatment, cells
were washed three times with ice-cold PBS and extracted with lysis buffer as described
earlier in Chapter 2. Cell lysates were then subjected to electrophoresis and Western
immunoblotting, and transferred proteins were probed against anti-phospho ERK (p-ERK)
and anti-phospho Akt (p-Akt) antibodies, respectively.
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4.2.5. Effect of ECMIX on corneal epithelial cell cycle protein expression
To evaluate the effect of ECMIX on cell cycle protein expression in PCECs, 60%
to 70% confluent cells were starved overnight in DMEM/F12 with 0.25% FBS. Cells were
then treated with ECMIX (72, 144 or 216 µg/mL) for 24 hours. Cells treated with
keratinocyte growth factor (KGF, 10 ng/mL), a known stimulator of corneal epithelial cell
cycle protein expression, was used as a positive control. Following treatment, cells were
washed three times with ice-cold PBS and extracted with lysis buffer as described above.
Cell lysates were then subjected to Western immunoblotting, and transferred proteins were
immunoblotted to identify various cell cycle proteins as indicated in the results.

4.2.6. Effect of ECMIX on epithelial cell regeneration in corneas incubated under organculture conditions
De-epithelialized corneas were seeded with epithelial cells in the presence or
absence of ECMIX were subjected to ex vivo organ culture conditions (described in detail
earlier in chapter 2). Cultured primary HCECs or PCECs were suspended in ECMIX. A 510 µL aliquot of this ECMIX-cell suspension containing 5000-30000 cells was applied on
the epithelial debrided corneal surface.

4.2.7. Statistical Analysis
Statistical data represented as the mean ± SD and analyzed using Student’s t-test or
ANOVA; p < 0.05 was considered statistically significant.
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4.3. Results
4.3.1. ECMIX preparation and components identified in ECMIX
The method developed to isolate corneal ECM involved liquefication of the cornea
in its entirety. The bulk of the cornea is composed of stroma (90-95% by weight) that is
rich in ECM proteins. It is appropriate to consider that ECMIX contains all the stromal
ECM components. Electrophoresis of ECMIX revealed the presence of two strong bands
at a molecular weight of 130–140 kDa, and a high molecular weight band >250 kDa. These
major bands are characteristic of collagens. Multiple polypeptide bands of different
molecular size were also present in minor amounts.
Collagen I is the most abundant component in the corneal stromal ECM. We have
identified this major protein in ECMIX by Western immunoblotting after probing with
anti-collagen I antibody. As illustrated in Figure 25 B, three bands of molecular weight at
250, 130-140 and 75 kDa appeared indicating the presence of Col I in ECMIX. By using
Col IV antibody, we were also able to identify the presence of 250 and 140 kDa Col IV
protein bands in ECMIX. In addition, we have also detected the presence of 100-120 kDa
band of fibronectin peptide in ECMIX. In this study, we have not investigated the presence
of other stromal ECM components in ECMIX.

4.3.2. Organization of the fibrillar network in ECMIX: Analyzing ECMIX by using
Scanning electron microscopy (SEM) analysis
The organization of the collagen fiber arrangement observed in ECMIX is similar
to that found in the corneal stroma (compare Figure 26 C and 26 D). This suggests that the
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preparation process did not alter the native fibrillar organization of the stromal matrix
components.

4.3.3. Activation of ERK and PI3-K/Akt in by ECMIX
Phosphoinositide-3-kinase (PI3-k/Akt) and extracellular signal-regulated kinases
(ERK1/2) signaling cascades play a critical role in cell proliferation in most mammalian
tissues. Previous studies from this laboratory (Pothula, Chandrasekher, and Bazan, 2013)
have demonstrated that collagens, laminin, and fibronectin stimulate these signal mediators
in corneal epithelial cells. Therefore, ECMIX that comprises many ECM proteins native to
the cornea was evaluated for its ability to influence the signaling mediated by PI-3K/Akt
in PCECs. After 5 minutes of incubation with ECMIX, a statistically significant increase
in ERK1/2 phosphorylation was observed, which persisted until 20 minutes (Figure 27 A).
The percentage of increase in ERK1/2 activation in ECMIX-treated cells over untreated
controls was approximately 150-250% over the studied time points (Figure 27 A).
Similarly, a statistically significant increase in phosphorylation of Akt (~130%) was also
observed in the presence of ECMIX after 10 minutes (Figure 27 B).

Activated

(phosphorylated) forms of Akt and ERK triggers the downstream signaling cascades.

4.3.4. Upregulation of corneal epithelial cell cycle proteins expression by ECMIX
Under physiological conditions, to maintain the propagation and growth of the
corneal epithelium, modulation of cell cycle progression and arrest must be sustained. As
ECMIX exhibited activation of both ERK and PI3-k/Akt signaling cascades, to provide
further evidence that ECMIX is a promoter of epithelial growth, its influence on cell cycle
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promoting proteins including cyclins, cell division cycle protein Cdc42, CDKs and cell
cycle inhibitory protein p21 (waf1/cip1) was evaluated. In the presence of ECMIX, the
expression level of the G1-S cell cycle transition regulatory protein cyclin D1 and its
partner CDK4 were increased by 120% (Figure 29 D) and 100% (Figure 28 B),
respectively, compared to control cells not treated with ECMIX. There was a significantly
higher expression (up to 228%) in the amount of the S-phase regulatory protein cyclin E
(Figure 29 E), and up to 250% in the levels of its partner protein CDK2 (Figure 28 A) in
ECMIX treated cells. Levels of the G2-M phase regulatory protein cyclin A was also
enhanced up to 122% in ECMIX treated PCECs (Figure 29 A). Previous studies have
shown that Cdc42 is a promoter of corneal epithelial cell division and is associated with
Cyclin/CDK complex (Pothula, Bazan, & Chandrasekher, 2013). In the current study,
approximately 250% increase in cdc42 expression in the cells treated with ECMIX
compared to untreated control cells was observed (Figure 29 C).
The increased expression of p21cip, which is well known to inhibit the cell cycle
transition from G1 to S, along with the upregulated cell cyclins possibly suggest that only
a minor portion of the cyclin-CDK complexes are associated with p21cip after ECMIX
treatment. The protein could bind preferentially to one cyclin-CDK complex; thus its effect
does not cause to the inhibition of all other CDK-cyclin complexes. These results strongly
suggest that ECMIX promotes epithelial growth at least in part through enhancing the cell
cycle progression involving p21, cyclin D1, CDK4, CDK2, cyclin A, cyclin E, and Cdc42.
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4.3.5. ECMIX supported epithelial cell regeneration in corneas subjected to epithelial
injury
To evaluate whether ECMIX can influence epithelial growth irrespective of tissue
and cell source, human and porcine cornea buttons were seeded in an organ culture setting
with PCECs and HCECs. In the first experiment, PCECs were suspended in ECMIX and
seeded on the porcine cornea buttons and then cultured for 24 hours. As illustrated in Figure
30 (B2) and Figure (31) C2, in ECMIX-treated corneas, attachment and growth of PCECs
(e.g., granule-like structures) over the underlying denuded surface was robust compared to
the untreated buttons (Figure 30 B1 and 31 C1). When viewed under the microscope, 4
hours after seeding, epithelial cells on the ECMIX treated buttons were observed to grow
and organize in the form of clusters giving rise to a sheet mimicking the natural corneal
epithelium (Figure 30 B2). The cells on the control corneas were also proliferating, but
they did not show signs of clustering or sheet formation (Figure 30 B1). The formation of
cell clusters coupled with an approximately 40% enhanced cell growth in the ECMIX
treated cornea buttons (Figure 30 D) was a significantly superior outcome compared to the
natural regeneration observed in the untreated control buttons. After 24 hours, there were
almost no empty spaces left on the surface of the ECMIX treated buttons (Figure 30 C2),
confirming that epithelial cell sheets had covered the entire denuded cornea.
To further confirm that ECMIX’s proliferative influence on epithelium
regeneration can be translatable to the clinic, the same ex-vivo experiment was performed
using human cadaver corneas. In the experiment with human cornea buttons (Figure 31),
HCECs in the presence of ECMIX started to migrate after 4 hours of seeding (Figure 31
B) and completely covered the denuded surface with an epithelial sheet by 48 hours (Figure
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31 D). After 4 days, the epithelial organization appeared similar to that of the natural intact
corneal epithelium (Figure 31 E and 31 F respectively).

4.4. Discussion
In this study, we report the method for preparing a cornea-derived liquid ECM
composition. To the best of our knowledge, there is no other method available currently to
completely solubilize the cornea in this manner. The process of this method is proprietary,
and a U.S. patent has been filed (October 2017: Tissue-Derived Biomaterial composition
and methods for Ocular and other Therapeutic Applications - US Patent Pending). While
experiments performed, have confirmed the presence of Col I, Col IV and fibronectin,
several other components of extracellular matrix native to the corneal stroma are likely to
be present in ECMIX preparation. Identification of all their presence is beyond the scope
of this work. Based on the information available in the literature, ECMIX may contain
other components native to the corneal stroma such as collagen types III, V, VI, IX, XII,
and XIV (Michelacci, 2003). Other reported ECM proteins like laminin (Bystrom,
Virtanen, Rousselle, Gullberg, & Pedrosa-Domellof, 2006), could also be present.
The liquefied whole cornea material, ECMIX, comprises components native to the
cornea needed for a biomaterial which can be employed for the treatment of multiple
corneal disorders such as recurrent epithelial disorders, external epithelial injuries, stromal
and endothelial dystrophies. ECMIX approximates the composition of an adult human
corneal stroma.
ECMIX may contain non-extracellular matrix proteins reported to be present in the
cornea, e.g., corneal crystallin and proteoglycans including both protein components as
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decorin, lumican, keratocan and carbohydrate components as keratan sulfate and
chondroitin sulfate (Chakravarti et al., 2006).
The ex-vivo organ culture experiments with epithelial debridement showed a
significant increase in epithelial cell regeneration in the presence of ECMIX. This can be
attributed to the ECMIX potential to stimulate gene expression, promoting signaling
cascades that include ERK and PI3-K. It is possible that their activation caused the
enhanced expression of several cell cycle proteins that are required for cell cycle
progression that results in increased cell regeneration. Hence, ECMIX is a suitable
biomaterial for employment as a therapeutic for treating corneal dystrophies where there is
a significant loss of epithelium. There are numerous reports of other types of biomaterial
that have been developed and used to treat ocular disorders, but all or most of them utilize
components from exogenous sources and tissues (Ghezzi, Rnjak-Kovacina, & Kaplan,
2015; Lawrence, Marchant, Pindrus, Omenetto, & Kaplan, 2009; Levis et al., 2015;
Ruberti, Sinha Roy, & Roberts, 2011; Tsai et al., 2015) which may fail to activate the
intrinsic cellular processes required for cell regeneration.
Corneal epithelial wound healing is a complicated process that involves three main
phases: cell adhesion, migration to replenish the wound area, cell division, and growth for
the formation of the intricately organized multiple epithelia (Pothula et al., 2013). ECMIX
serves as the ideal candidate to achieve all these events and influence cell regeneration.
While ECMIX in its liquid form could be used as a topical therapeutic agent to target
epithelial regeneration, it could also be fabricated into a corneal construct for
transplantation purposes where the corneal damage is severe. As ECMIX contains natural
components of the corneal stroma as well as the native collagen fibrillar organization, a
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construct made of ECMIX can integrate well with the tissue when employed for
transplantation purposes.
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CHAPTER 5
BIOENGINEERING OF ECMIX-BASED CORNEAL CONSTRUCTS
FOR TRANSPLANTATION

5.1. Introduction
Any injury or disease leading to scarring and opacification of transparent cornea
can result in visual impairment. Vision loss due to corneal blindness has affected almost
10 million people worldwide (Bourne et al., 2018). The primary treatment for irreversible
corneal damage is grafting of allogenic corneal transplant (George & Larkin, 2004).
Unfortunately, there is a severe shortage of healthy transplantable donor corneas globally,
making treatment difficult (Rock, Bartz-Schmidt, & Rock, 2018). The lack of donor
corneal tissues and a steady demand for transplantation procedures have driven research
efforts to develop different biomimetic scaffolds that could be used as corneal replacements
(Ghezzi et al., 2015). Fabrication of corneal equivalents that include anterior corneal
transplants, and decellularized stromal substitutes are currently being explored (Alio Del
Barrio et al., 2018; Cruz et al., 2017; Yamaguchi & Takezawa, 2018).
The cornea is rich in ECM, and any functional substitute must possess a similar
environment. Hence, corneal regenerative medicine has targeted ECM components for
developing the a suitable corneal substitute (Kong & Mi, 2016; Lin et al., 2017). The ECM
components in cornea, are pivotal to maintain tissue transparency, as well as cellular
survival, proliferation and growth (Michelacci, 2003; Qazi et al., 2010).
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Research studies have been undertaken to decellularize corneas, for use as a corneal
replacement (Alio Del Barrio et al., 2018; Lin et al., 2017, Shafiq, Gemeinhart, Yue, &
Djalilian, 2012; S. L. Wilson, Sidney, Dunphy, Rose, & Hopkinson, 2013; Yam et al.,
2016).). Although some of these scaffolds contained corneal ECM components, the
structural integrity of the ECM proteins could have been compromised due to utilization
of pepsin during the decellularization process resulting in an altered stromal
microenvironment leading to improper vision.
Another widely explored approach undertaken is development of ECM based
hydrogels. Collagen type I has been the most abundantly used material to fabricate these
hydrogels as it is the major constituent of the corneal ECM (Chattopadhyay & Raines,
2014; Parenteau-Bareil, Gauvin, & Berthod, 2010; Rose et al., 2014). However, the corneal
ECM also contains many other components such as other collagen types (II, IV, V, VI, and
VII), GAGs and growth factors. Very few studies have explored the utilization of multiple
corneal ECM components to design a suitable cornea-like construct.
Injuries or diseases such as recurrent epithelial erosions, Fuch’s endothelial
dystrophy, and modest anterior corneal wounds require only a selective cellular layer of
the tissue to be replenished (Das & Seitz, 2008; Eghrari & Gottsch, 2010). These
conditions, fortunately, do not damage the entire cornea. However, for injuries that result
in severe stromal damage that needs corneal transplantation, an ideal replacement would
be a construct that is capable of supporting all three different corneal cells. ECMIX, a
cornea-derived biomaterial whose composition approximates that of the cornea is suitable
for the fabrication of a transplantable corneal construct. Further, as described in Chapter 4,
ECMIX possesses biological properties similar to the native tissue, therefore it would be
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appropriate to utilize ECMIX biomaterial for fabricating a corneal equivalent. The studies
presented in this chapter describe the development of a cornea construct utilizing ECMIX
and evaluation of the construct’s biophysical and biological characteristics.

5.2. Methods
5.2.1. Viscosity and Viscoelastic properties of ECMIX
Viscosity and viscoelastic properties of ECMIX were evaluated using an AR-2000
rheometer (TA Instruments) containing a 40 mm-diameter parallel plate geometry tool.
The methods used are described in detail earlier in Chapter 2. Five ml of ECMIX solution
was transferred to the rheometer bottom base plate that was pre-equilibrated at 250C.
Dynamic viscosity of ECMIX was evaluated at shear rates ranging from 0.01 to 1 s-1 at
250C. Then, the viscoelasticity of ECMIX solution was assessed by performing a frequency
sweep between 0 to 70 rad/s at a constant stress of 0.79 Pa.

5.2.2. Fabrication of ECMIX constructs
ECMIX was chemically cross-linked with glutaraldehyde to prepare constructs of
desired thickness (μM) and diameter. Equal volumes of ECMIX and 10% glutaraldehyde
solution (weight/volume) were allowed to react in a 60-mm tissue culture dish to generate
the construct. Glutaraldehyde crosslinking reaction was carried out at room temperature
(250C) for 15-20 minutes. After the reaction was complete, excess unreacted
glutaraldehyde was pipetted out, and ECMIX constructs were washed extensively with
sterile PBS. The constructs were transferred to a new petridish after each wash. The
constructs were equilibrated with serum-free DMEM/F12 medium for 1-2 days to eliminate
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any residual unreacted glutaraldehyde from the hydrogel. The medium was replaced three
times during this period.

5.2.3. Optical properties of ECMIX and ECMIX construct
Transparency of ECMIX solution and the constructs was determined by measuring
the absorbance in the visible range using a Multiscan Spectrum (Molecular Devices). The
method used is described in detail in Chapter 2. Human cornea transparency values were
taken from established literature (Van Den Berg & Tan, 1962).
The refractive index of ECMIX solution and the constructs was determined using
an Abbe’s refractometer with standard monochromatic light at a wavelength of 589 nm.
The method used is described in detail in Chapter 2. The reported data are the averages of
three separate measurements for each sample. Glycerol was used as a reference sample in
both transmittance and RI studies.

5.2.4. SEM analysis of ECMIX constructs
ECMIX constructs were prepared for scanning electron microscopy as described in
Chapter 2. SEM images were acquired using a Hitachi Scanning Electron Microscope with
an Energy Dispersive X-ray analysis at different magnifications. Samples of fresh deepithelialized human corneas subjected to similar conditions were used as controls.
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5.2.5. Evaluation of ECMIX construct’s degree of swelling
The degree of swelling for ECMIX constructs was determined using methods
described in detail earlier in Chapter 2. The swelling ratio was determined from the
equation,
Swelling ratio = Swollen weight of the construct (Ws)
The dry weight of the construct (Wd)
The ratio of the weight of water in the construct to the weight of the construct at equilibrium
hydration, expressed as a percentage, for each time point studied,
Degree of swelling = (Ws – Wd)
Wd

5.2.6. Evaluation of ECMIX construct’s glucose permeation property
Glucose permeability of ECMIX construct was evaluated using a Franz diffusion
setup (PermeGear, Inc., PA). The methods used are described in detail in Chapter 2. Intact
corneas were used as controls where the corneal endothelial and epithelial side faced the
donor and receptor chambers, respectively.

5.2.7. Evaluation of effects of proteolytic enzymes, and temperature on ECMIX constructs,
and the degradability of the constructs under storage conditions
ECMIX constructs were subjected to proteolytic digestion by collagenase (Sigma
Aldrich type I or type IV) at 370C for 30 mins, 4 hours and 8 hours, with 50 µl of
collagenase solution (0.4-4 units/µl).
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To evaluate the temperature effect on ECMIX constructs, the constructs were
incubated in PBS for 6-8 hours at -80, -20, 4, 25, 37 and 600C respectively. Gel integrity
was visualized.
The degradability of the constructs under storage conditions were evaluated by
incubating the constructs in 50 µl of sterile PBS for 30 days. After the incubations were
complete, tubes were spun at 14000 rpm for 5 minutes and supernatant concentrated using
a 30,000 MWCO filter. Concentrated samples were pooled from triplicate incubations
before subjecting to SDS-PAGE and Western immunoblots.

5.2.8. Evaluation of corneal cell growth on ECMIX constructs
(a) To assess the ability of the ECMIX constructs to promote cell growth, they were
seeded with primary human or porcine corneal epithelial cells or fibroblasts. Before
seeding the construct surface was gently dabbed with a sterile Kimwipe to ensure removal
of any moisture. The cell suspension was prepared in serum-free medium, and 2-5 µL of
this suspension containing 25000-30000 cells was applied on the construct surface. Serumfree DMEM/F12 culture medium (about 0.5 ml) was added dropwise around the edges of
the construct to maintain organ-culture conditions yet ensuring to leave the seeded surface
exposed to air. The constructs were maintained at 370C in tissue culture incubator for
different times. After completion of each study period, constructs were washed three times
with sterile PBS to remove any unattached cells and then imaged under the microscope for
cell growth and analysis.
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(b) In separate experiments, constructs were made in the wells of 96 well tissue
culture (~4 mm thick). Epithelial cells and fibroblasts were allowed to grow on the surface
of cylindrical constructs until confluency was reached. Then, transverse sections (~100
µm) were made using a blade in the middle of the construct. These sections were analyzed
with a Phase microscope for the presence of epithelial cells and fibroblasts.
(c) In other experiments, constructs that were confluent with epithelial cells were
employed as an explant and expansion of the cells originating from the construct was
assessed. Cells were allowed to grow out from the construct and attach onto the plate
surface. Once adequate cells had attached, constructs were displaced into a new plate. Cells
generated from the construct up to 30 days post-seeding were assessed. Explants were also
allowed to expand on de-epithelialized human corneas.

5.3. Results
5.3.1. Rheological properties of ECMIX
ECMIX viscosity was observed to decrease with higher applied shear rate values
as illustrated in Figure 32 A. Over the studied range of shear rates (s-1), viscosity values
were found to decrease linearly until about the maximum applied the shear rate of
0.8 s-1. The linear dip in ECMIX viscosity as shear rate was increased indicates it possesses
significant shear-thinning properties. This property indicates that if ECMIX is packed into
a syringe, and extruded out upon shear application, it could rapidly reform upon cessation
of applied mechanical load. This reforming nature of ECMIX would allow improved
material retention upon injection and the biomaterial could be clinically translated to in situ
gelation applications. Hence, ECMIX could be used as a device that minimizes potential
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embolization into the systemic circulation after application. Many studies have indicated
the importance of such a shear-thinning injectable nature in biomaterials to enable
minimize invasive delivery routes i.e., through percutaneous catheters or robotic surgical
techniques (Grover. G., Braden, R.L., Christman, K.L., 2013; Rodell C. B., Lee M. E.,
Wang H., Takebayashi S., Takayama T., Kawamura T., Arkles J. S., Dusaj N. N., DorseyS.
M., Witschey W. R. T., 2016). For corneal tissue regeneration applications, the
encapsulation of corneal cells within a construct that is made of ECMIX would also benefit
from its shear thinning injection parameters that can improve cell viability. In addition, for
3D bioprinting applications of ECMIX, its injectability parameters would also help
modulate both the resolution and stability of printed artificial organs.
Our experiments to study the elastic (storage G′) and viscous (loss G′′) moduli of
ECMIX revealed a higher storage compared to loss modulus, in the range of 0 to 70 rad/s
angular frequencies as illustrated in Figure 32 B. It was also observed that ECMIX
exhibited an increase in both the studied moduli with respect to applied frequency. The
high storage modulus of ECMIX is reflective of its ability to absorb energy, while the low
loss modulus indicates its propensity to lose energy, hence confirming that ECMIX
possesses a balanced viscoelastic profile. The cornea like any other tissur possesses a
characteristic biphasic structure encompassing a solid network that is responsible for the
elastic properties, while being surrounded by an aqueous solution. Hence, the superiority
of any biomaterial that proposes to reconstruct the cornea would be such a viscoelastic
profile.
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5.3.2. Fabrication of ECMIX constructs
ECMIX was prepared from fresh porcine corneas. The final product was a viscous
liquid that appeared colorless. Constructs of desired thickness (μM) and diameter were
successfully prepared by chemically cross-linking ECMIX with 10% glutaraldehyde
(Figure 33 A). The chemistry involved in this process is illustrated in Figure 33 B.
Glutaraldehyde reacts with amino groups available in corneal ECM molecules, which helps
to form a tightly crosslinked network between different ECM components. For example,
glutaraldehyde reacts with the ε-amino groups of lysine residues in collagen present in
ECMIX, then condenses to form a heterocyclic compound which subsequently undergoes
oxidation to a pyridinium ring. This helps to form cross-links readily between the
molecules.
Final ECMIX construct was colorless. Stiffness of the construct depended on the
concentration of glutaraldehyde used. At lower glutaraldehyde concentrations, constructs
were soft, and at higher concentrations the gels became stiffer. Qualitatively, all constructs
prepared with 10% glutaraldehyde possessed sufficient stiffness and were maneuverable
with forceps.

5.3.3. Optical properties of ECMIX
Transparency of prepared constructs was evaluated. The light transmission of
ECMIX was evaluated in the visible light spectrum (range: 400 to 700 nm). Established
reports show the human cornea transmits 80 to 94% of all incoming visible light. The
percentage transmittance of ECMIX in the studied visible spectrum range was calculated
as to be 87.4% ± 1.4, (Figure 34 A). As the human cornea transmits almost 80% of visible
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light, ECMIX’s capability to do the same would make it an excellent material to be utilized
for developing a tissue replacement.
ECMIX’s refractive index was also assessed using an Abbe refractometer. The
mean refractive index of the constructs was determined to be 1.335 (Figure 35 B), which
was similar to the refractive indices of anterior (1.373) and posterior cornea (1.380).

5.3.4. ECMIX constructs retained corneal fiber organization
The surface organization of ECMIX constructs was studied using scanning electron
microscopy (SEM). Micrographs revealed that construct retained the fibrous corneal
stromal architecture (Figure 36). The characteristic orientation of fibrillar structures with
interconnecting pores resembling a honeycomb arrangement as seen in the control deepithelialized corneas (Figure 36 A) was also observed in the construct (Figure 36 B).
Retaining the fiber arrangement of the stroma is vital for a biomaterial/scaffold to
serve as a functioning corneal substitute.

5.3.5. ECMIX constructs possess acceptable degree of swelling
Swelling is one of the critical parameters in the characterization of a construct that
is intended to be used as a corneal substitute as it will be potentially exposed to aqueous
environments in physiological conditions.
To evaluate the degree of swelling in prepared constructs, swelling tests at 250C
were conducted. The observed swelling characteristics of these constructs at room
temperature are shown in Figure 37. The water content of the gels increased in all studied
samples. The difference between wet weight and dried weight of the construct is taken as
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total water content which is 100%. The water absorbed by the completely dried gels after
2 hours of exposure in water was about 34% of what was originally present in wet gels.
After 24 hours of exposure, the water level increased to 55%. After exposure to water for
3 days all samples were rehydrated to the water levels originally present in the construct.

5.3.6. Glucose permeation through ECMIX constructs
Glucose is one of the major nutrients essential to corneal health. Under
physiological conditions, glucose permeates by passive diffusion utilizing a concentration
gradient from the aqueous humor into the cornea (Gaudana, Ananthula, Parenky, & Mitra,
2010). Hence, a construct must be conducive to glucose movement, just like the cornea.
In this study, the prepared ECMIX constructs were evaluated for their capacity to
allow the movement of glucose. Figure 38 shows the the amount of glucose (μM) that
permeated through the constructs as compared to human corneas. Results show that the
amount of permeated glucose through the ECMIX constructs was 50% more than the
human corneas.

5.3.7. Stability of ECMIX constructs under various conditions
ECMIX constructs are found to be stable under temperatures ranging from -80 to
60oC. Exposure to these temperatures did not cause any changes to its appearance as seen
with the naked eye. A critical factor for a corneal for proper functioning of a corneal
construct is its stability to a wide range of temperatures.
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In addition, resistance to loss of integrity over a significant amount of time is also
necessary for proper storage of such prosthetics. A corneal scaffold that fails these key
criteria can hinder functional efficiency.
As MMPs are expressed in the corneal stroma, the construct should be be resistant
to collagenolytic enzymes. In our studies, ECMIX construct was observed to be resistant
to proteolytic degradation. The constructs were observed to be stable without any change
in integrity after incubation in tissue culture incubator when observed for up to 30 days in
the presence of collagenase as evidenced by absence of any degraded peptides in the SDSPAGE gels/Western immunoblots probed with specific anti-collagen antibodies.
Lastly, ECMIX construct was stable to all the temperatures used in the current study
(-80 to 600C), and no morphological changes were observed. The inertness of ECMIX
construct promises higher functioning efficiency as a corneal substitute.

5.3.8. Corneal cell growth on ECMIX constructs
To evaluate the ability of prepared ECMIX constructs to support corneal cell
growth, both isolated primary human corneal epithelial cells and fibroblasts were seeded
on the surface of the construct. Both epithelial cells and fibroblasts were able to populate
the construct surface readily, reaching confluence within 5 days. Epithelial cells formed a
sheet on the construct surface resembling the epithelium present in the natural cornea
(Figure 39 B and C). Similar to the cornea, ECMIX construct surface caused the generation
of multiple cell layers (Figure 40B). At least 2-3 layers of freshly populated epithelial cells
were detected on the construct surface. Growth of the epithelial cells were confined only
to the construct surface (Figure 40C) and did not infiltrate the interior of the construct.
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While fibroblasts grew on the construct surface (Figure 39 D and E), cells infiltrated the
construct interior as well (Figure 40 C).
In our study, constructs containing confluent layer of epithelial cells were able to
generate new, healthy cells over a long period of time. A 30 day old epithelial construct
was able to populate denuded human corneal epithelial surface (Figure 41 B). This
observation suggests that ECMIX construct could be used to replace the tissue as an explant
that generates fresh epithelial cells. Sustained cell-regenerating potential of ECMIX
construct would also be useful for the treatment of difficult-to-heal corneal epithelial
injuries such as RCES.
Epithelial cells growing on the construct expressed cytokeratin 3, a marker specific
to corneal epithelial cells (Figure 40A) confirming that the construct did not alter the
epithelial cell phenotype.

5.4. Discussion
ECM in the cornea is helpful in several ways to promote cellular development and
homeostasis. As each tissue is different, ECM in the cornea serves specifically a unique
environment that supports and maintains the health of its cells within the tissue. Shortage
of healthy transplantable tissues to treat severe corneal blindness has necessitated the need
to design a suitable corneal substitute. Many of these designs have employed ECM
components from an exogenous source (Tsai, Hsu, Hung, Chang, & Cheng, 2015; S. L.
Wilson et al., 2012). Some of the current state-of-art products developed to serve as a
potential replacement for the corneal stroma include decellularized porcine corneas (Lin et
al., 2017), human amniotic membranes (Yuan, Wang, Lin, Chou, & Li, 2014) and artificial
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corneal scaffolds that can aid in keratoprosthesis (Bentley, Murphy, Li, Carlsson, &
Griffith, 2010). Keratoprosthesis is a surgical procedure where a damaged cornea is
replaced with an artificial prosthetic. Traditionally, keratoprosthesis is performed on
patients after he/she has had a failure of one or more donor corneal transplants. The surgery
is performed to restore vision in patients suffering from severely damaged cornea due to
congenital disabilities, infections, injuries, and burns. Despite the achievement, many of
these products are limited in their action and fail to properly integrate into the host tissue.
In addition, currently used biomaterials for the development of corneal prosthetics possess
the risk of invoking an initial inflammatory response that eventually results in a chronic
inflammatory immune response (Meek & Knupp, 2015; Nishida et al., 2015; Peh et al.,
2011; Torricelli et al., 2013).
ECMIX-based devices are immune privileged and may not induce the typical series
of host reactions to foreign materials when employed for corneal tissue engineering. The
reason behind is that these systems possess the innate stromal architecture and native
corneal composition. However, further experiments are required to validate this notion.
Specific experiments evaluating ECMIX’s host privilege concerning minimizing foreign
body reaction will be critical to establish its clinical compliance conclusively.
In this study, the methods and composition for preparing a corneal ECM derived
construct that can potentially support the healing of various ocular disorders is described.
ECMIX construct by comprising naturally derived ECM molecules typically holds
immense translatable potential as it offers better biocompatibility, less immunogenicity,
and superior host-graft integration.
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In the current study, we report the fabrication of a cornea construct by chemically
crosslinking the liquid biomaterial ECMIX. Our results indicated that ECMIX construct
has a soft-to-hard gel consistency. Corneas exhibit a significant viscoelastic nature that is
critical for tissue functioning and hence ECMIX’s balanced stiffness and fluidity could
greatly supplement this property. While searching for the perfect crosslinker to enhance
the ECMIX liquid rigidity, various protein crosslinkers were tested including genipin, and
a pectin-calcium chloride model. Although most of them did achieve to improve the
stiffness for ECMIX, none of them were able to generate the rigidity that 10%
glutaraldehyde provided. Lower concentrations of glutaraldehyde were also not able to
crosslink ECMIX to a significantly acceptable stiffness.
Constructs supported the growth and proliferation of corneal epithelial and
fibroblast cells. A significant disadvantage hindering the applicability of many of the
constructs being developed for corneal applications has been their transparency and poor
optical properties (Mirazul, I., Buznyk, O., Reddy,J., Pasyechnikova, N., Alarcon, E., &
Griffith, M., 2018). Optical property evaluation of ECMIX construct revealed that it could
accommodate a significantly similar profile as present in the cornea. SEM studies showed
that ECMIX construct was retained the intricate corneal ECM fiber arrangement. The
outcome of this observation could be the reason why the cytocompatibility of the construct
was extremely high while still homing cornea-like transparency. ECMIX construct by
possessing an acceptable degree of swelling, and glucose permeability reinforce the
potential to be functionally useful as a corneal alternative in more ways than one.
A platform that can serve as a substrate for all the corneal cell types, both
exclusively and collectively, would provide an excellent testing base for numerous in vitro
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studies addressing corneal intercellular signaling, cell, and tissue physiology studies or
drug-protein interactions. ECMIX construct by mimicking the native biochemical, and
biomechanical microenvironment native to the corneal cells has a significant influence on
cell behavior and growth promotion.
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CHAPTER 6
SUMMARY AND CONCLUSION

This research is undertaken to develop an alternative therapeutic approach for
corneal dystrophies as existing therapies do not adequately treat the underlying cause,
which is cell regeneration. ECM-based therapeutic approaches are currently being explored
to promote tissue regeneration. Because the cornea is composed almost entirely of ECM,
we hypothesized that involving ECM molecules would be an appropriate strategy to design
therapies for difficult-to-repair corneal dystrophies.
ECM proteins and growth factors have been reported to be released in response to
corneal injuries to promote the healing process. In this study, we have observed the
secretion of three ECM proteins, collagen I, collagen IV and fibronectin from injured as
well as healthy corneas in ex-vivo conditions. As collagen, I is the most abundant
component of all ECMs in the cornea that provides structural support to the tissue and
collagen IV and fibronectin constitute the basement membrane that anchor the corneal
epithelium, we believe that their release would play a critical role in tissue repair. Further,
the release of ECM proteins from uninjured corneas indicates that they could mediate
signaling crosstalk between different corneal cellular layers to maintain physiological
processes such as cell adhesion, proliferation, migration, and growth. In support of this, we
demonstrated that the medium containing the released ECM proteins is capable of
promoting the regeneration of epithelium on human corneas in organ culture.
Based on the molecular weight profile, the released Col I and Col IV appears to be
similar to the Col I and Col IV of the stromal ECM. This suggests that the released proteins
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may have generated not as a result of the degradation of corneal ECM, but secreted by the
activated keratocytes for healing purposes. Therefore, utilizing the corneal ECM as a
therapeutic material for treating corneal dystrophies is beneficial.
We have developed a method for preparing cornea-derived ECM composition for
the purpose of conducting experiments to validate above indicated views. The biomaterial
that is prepared is a liquefied corneal tissue in its entirety. Therefore, we expect the
composition of this biomaterial to be similar to that of the corneal tissue. The prepared
biomaterial, ECMIX, is the first of its kind liquefied cornea-derived ECM and to the best
of our knowledge, currently there is no other method available to solubilize the cornea
completely in this manner. The process of this method is proprietary, and a U.S. patent has
been filed. At this time there is no commercially available clinical product similar to
ECMIX which can be employed for therapeutic purposes.
The biological characteristics of ECMIX have been evaluated in this study. ECMIX
stimulated intracellular growth signaling cascades (ERK and Akt) and upregulated corneal
epithelial cell cycle progressing protein (cyclins and cyclin-dependent kinases) expression.
This implies that ECMIX contains cell growth, promoting potential. Our ex-vivo organ
culture experiments with epithelial debridement showed a significant increase in epithelial
cell regeneration in the presence of ECMIX. These findings indicate that ECMIX is a
suitable biomaterial that can be used for epithelial regeneration in conditions where
restoration of healthy epithelium is necessary (anterior cornea dystrophies like recurrent
epithelial erosions, limbal epithelial cell deficiencies, and external epithelial injuries), to
alleviate the problem.
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In some situations, damage to the cornea is irreparable. For example, chemical
burns, mechanical injuries, and some diseases can cause significant tissue destruction
resulting in loss of structural integrity and complete cell regeneration capability. In such
conditions tissue transplantation is the only feasible option for treatment. As ECMIX is
rich in corneal ECM components and it has the capability to support cell growth, it can be
utilized for the development of cornea-like constructs. Further, ECMIX exhibited
appropriate optical properties (transmittance and refractive index) and viscoelastic
characteristics needed for a biomaterial to be fabricated into corneal replacement.
We employed ECMIX to fabricate a cornea-like construct by chemical crosslinking
with glutaraldehyde. The construct is stable to temperature (-80oC-60oC) and proteolytic
degradation. The construct is transparent, capable of absorbing water to maintain hydration
levels comparable to the cornea and is permeable to nutrients such as glucose. ECMIX
construct also supported the growth of corneal cells (epithelial and fibroblasts). The
epithelial cell growth was confined to the construct surface while the fibroblasts could grow
inside the construct similar to corneal keratocytes/fibroblasts that grow in the stroma.
Epithelial cells which grew on the surface of the construct formed multiple layers (2-3
layers) similar to corneal epithelium composed of 5-7 layers of cells. Growth of epithelial
cells on the construct sustained for 30 days and beyond. Furthermore, the ECMIX scaffold
fibrillar architecture was found to be similar to the corneal stroma as determined by
scanning electron microscopy studies. These results suggest that constructs fabricated
using ECMIX are suitable for transplantation purposes.
In summary, liquid ECMIX is an appropriate therapeutic material for topical
applications to treat limbal epithelial stem cell deficiency, basement membrane related
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dystrophies, and recurrent epithelial erosions or repairing corneal damage caused by
external injuries. ECMIX based corneal construct could function as a suitable corneal
prosthetic. A cornea-like construct can be made by fusing three scaffolds of cross-linked
ECMIX, each seeded with epithelial cells, keratocytes, and endothelial cells, respectively.
Alternatively, each of the above scaffolds can be used as a therapeutic device on its own to
treat cornea cell-specific disorders (Fuch’s endothelial dystrophy: endothelial cells,
keratoconus: stromal keratocytes and corneal epithelial basement membrane dystrophy:
epithelial cells).
Further studies are needed to identify the entire ECMIX composition and
preclinical animal experiments using a specific cornea disease model need to be performed
to validate its usefulness in a clinical setup. Compounds that exhibit viscoelastic properties
are being employed as adhesive materials to seal cornea incisions that are made during
surgeries like in cataract and LASIK flaps, and also to seal combat-related ocular injuries
(eye globe ruptures). Because ECMIX possesses a significant viscoelastic property, it can
be chemically engineered into a bioadhesive material to be used for above purposes.
Currently, attempts are being made to 3D print corneas using biological materials. Because
our liquid ECMIX contains essentially all components native to the cornea, it could be
employed as a bio-ink for 3D printing of corneas.

Figure 1: The Extracellular matrix: A, Extracellular matrix is made up of water, proteins, and proteoglycans that often form
large bundles or complexes that bind together and to the cells of the tissue. Although the makeup of ECM varies from tissue
to tissue, it usually includes some connections to integrins in the plasma membranes, thereby allowing for structural integrity,
as well as communication and coordination within the tissue. B, A detailed view of a proteoglycan complex shows many
proteoglycans, each with a protein backbone and attached carbohydrate subunits—all held together by a polysaccharide
chain. C, Detailed view of a collagen bundle showing the individual collagen fibers within it (Halper & Kjaer, 2014).
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Figure 2A: The Collagen triple-helix. (Silva et al., 2014)
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Figure 2B: Distribution of amino acids in the collagen triple-helix. (Silva et al., 2014)
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Figure 3: Collagens fibers. (A: Collagen fibers of human skin dermis seen using
Transmission electron microscopy, where the fibers are stained pink with hematoxylineosin; B: A scanning electron micrograph showing three-dimensional structure of collagen
fibers in mouse periodontium C: Longitudinal section of collagen fiber in the human skin
dermis as seen using Light Microscopy. The arrowheads represent single collagen fibrils
running independently; D: A closer view of collagen fibers in the rat aortic adventitia. Here
the arrowheads represent filamentous structures connecting adjacent collagen fibrils).
(Ushiki, 2002)

85

c

Figure 4: Collagens fibers observed using transmission electron microscopy and Atomic
force microscopy. (a: Collagen fibers in mouse tail tendon stained with lead citrate and
uranyl acetate, arrowheads indicate D-bands. b: Collagen fibers in mouse tail tendon
stained phosphotungstic acid: the characteristic alteration in dark and light zones observed
along the fibrils. c: Atomic force micrograph of scleral collagen fibril where the fibril has
periodical grooves and ridges. (Ushiki, 2002)

Fibers
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Figure 5: Cascade of events leading to collagen synthesis (Lopez, Gonzalez, & Diez, 2010)

Fibers

Fibril

Figure 6: Collagen intramolecular crosslinking: Intra and intermolecular collagen cross-linking results in an increase in
collagen density (Sprenger, Plymate, & Reed, 2010)

Trimers
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Figure 7: Chemical structures of different types of GAGs present in the ECM. The
repeating disaccharide units of (A) Hyaluronate composed of D-glucuronate (GlcA) plus
N-Acetylglucosamine (GlcNAc) and the linkage is β(1,3); (B) Dermatan sulfate composed
of L-iduronate (IdoA) or D-glucuronate (GlcA) plus GalNAc-4-sulfate; GlcA and IdoA
sulfated and the linkages are β(1,3) if GlcA, α(1,3) if IdoA; (C) Chondroitin sulfate
composed of D-glucuronate (GlcA) and N-Acetylgalactosamine (GalNAc-4- or 6-sulfate)
and the linkage is β(1,3) (the figure contains GalNAc 4-sulfate) and (D) Keratan sulfate
composed of galactose plus GlcNAc-6-sulfate and the linkage is β(1,4) (Pichert et al.,
2012).

via a trisaccharide linkage.

Figure 8: GAG linkage to core protein in a proteoglycan. GAGs are linked to the protein core of the proteoglycan
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Figure 9A: Eye transverse scan. Several muscles and ligaments surround and help hold the
eyeball in position (Khitri & Demer, 2010).

Figure 9B: The cross-section of the eye (Michelacci, 2003).
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Figure 10: The corneal stroma. The corneal stroma comprises of a highly organized ground ECM
in which keratocytes are sparsely embedded. Some of the significant GAGs present in the ECM are
keratan sulfate, chondroitin sulfate, and dermatan sulfate. The primary function of the corneal
stromal ECM is to maintain transparency, ensure the spatial arrangement of the collagen fibrils and
maintain the hydrophilicity of the whole tissue

away by the tear on the anterior surface.

get pushed upward to differentiate into polyhedral shape and eventually become squamous before being washed

epithelial cells homes the base. The cuboidal basal cells are only mitotic. During physiological turnover, basal cells

epithelial cells at the top are followed by 2-3 layers of polyhedral wing cells in the middle. A single layer of cuboidal

Figure 11: The corneal epithelial layers. The multi-layered corneal epithelium consists of five cell layers. Squamous
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Figure 12: Corneal stromal repair. An injury deep enough to harm the stroma also damages the overlying epithelium and basement
membrane. Injury triggers the release of cytokines into the stromal matrix. In presence of these cytokines, quiescent keratocytes
get differentiated into fibroblasts and eventually the repair phenotype, myofibroblasts. Myofibroblasts release the repair-specific
ECM proteins that mediate the biochemical processes required for healing starting off with fibrosis and haze formation. Although
necessary, it is this newly formed ECM components that are responsible for creating a non-uniform and erratic extracellular
matrix. [Adapted from (Chaurasia, Lim, Lakshminarayanan, & Mohan, 2015)]
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Figure 13: Corneal cell isolation. For epithelial cell harvest, freshly enucleated corneas
were incubated for 45 minutes, epithelial side down in HyQTase, a cell detachment
solution. Then, the epithelial cells were mechanically scraped off the anterior surface and
collected into a volume of serum-containing medium for culture. Although both cells
around the limbal section as well as from the center of the cornea were pooled during
collection, most of the mitotic cells originated from the limbal region. For stromal cell
harvest, de-epithelialized corneas were cut into small buttons and were subjected to
HyQTase treatment for 6-8 hours. Then, these buttons were incubated in tissue culture
plates in either serum-free medium (for keratocytes) or serum-containing medium (for
fibroblasts), until a suitable number of cells attached for culture.

Figure 14: ECM protein release kinetics from porcine corneas. (1) Freshly enucleated corneas were subjected to mechanical
epithelial debridement using a No. 15 scalpel blade. De-epithelialized corneas were then incubated in 1m/cornea of serum-free
medium for 4-60 hours. Conditioned medium (COCM) was collected periodically at specific time intervals and test corneas were
replenished with serum-free medium after every collection. Corneas with intact epithelium were used as controls. (2) Freshly
isolated corneal epithelial cells were treated with COCM and proliferative capacity was evaluated using CytQuant Assay. COCM
collected from intact corneas was used as control.

Medium was collected at different time
intervals (4-60 hours)

95

Figure 15: Ex-vivo organ culture studies with COCM/ECMIX on human/porcine corneas. De-epithelialized buttons were cut out
from the center of the cornea, to be used as scaffolds. A drop of COCM/ECMIX suspension dispersed with epithelial cells were
added to the center of the button. The test buttons were then incubated for 4-24 hours at 370C, under organ culture conditions,
for the cells to attach and grow. In control cornea buttons, serum-free medium was used in place of ECMIX suspension or COCM.
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Figure 16: ECM peptides released from corneas after epithelial debridement. We have identified release of (A) collagen I (140
kDa and 75 kDa peptides), (B) fibronectin (250 kDa peptide) and (C) collagen IV (140 kDa peptide). As compared to control
uninjured corneas, de-epithelialized corneas released significantly higher amount of ECM proteins.
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Figure 17: Confirmation of collagenous nature of released ECM proteins. (A) Coomassie blue staining; Left lane, molecular
weight marker. (B) Western blot analysis after probing with anti-collagen type I and anti-collagen type IV; Left lane, molecular
weight marker.
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Figure 18: Differences in secretion amount of released ECM peptides between COCM
collected from injured and intact corneas during 0-60 hours study period (A: Col I; B:
Fibronectin and C: Col IV)
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Figure 19: Differences in secretion pattern of released ECM peptides between each time point in COCM collected from injured
and intact corneas during 0-60 hours study period (A: Col I-140 kDa; B: Col I-75 kDa; C: Fibronectin; and D: Col IV
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Figure 20: Proteolytic effect of COCM on stromal proteins. (A) Coomassie blue staining;
Left lane, molecular weight marker. (B) Western blot analysis after probing with anticollagen I and anti-collagen IV; Left lane, molecular weight marker.
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Figure 21: COCM promotes epithelial proliferation. Differences in an increase in cell
proliferation with COCM collected at different time points appears to be due to the
presence of varying levels of released ECM proteins. The experiment was conducted using
COCM from the epithelial-debrided corneas as it had more amount of released ECM
peptides compared to the uninjured cornea COCM. (*p < 0.05 Control vs different time
point medium)
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Figure 22: Ex vivo organ culture studies on human cadaver corneas. COCM treated corneas
showed a significantly higher amount of cell attachment and growth for both 4-hour and
24-hour samples. Also, epithelial sheet formation was observed in corneas treated with
COCM.

Figure 23: Possible wound-healing roles attributed to the released ECM peptides. After the loss of physiological homology during injury,
the immediately adjacent keratocytes at the site of injury get activated to become fibroblasts. These activated keratocytes mediate the
formation of new ECM peptides that include collagen I, IV and fibronectin. While collagen I and fibronectin help generate a provisional
basement membrane to maintain attachment of incoming healthy epithelial cells, an underlying cascade of events regulate the formation of
collagen IV which is an integral component of the permanent basement membrane. With the gradual reconstruction of the permanent
basement membrane, the rate of release of collagen I and fibronectin goes down, as the tissues slowly regains its health.
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Corneas were mechanically deepithelialized
using a No. 15 scalpel blade

Corneas were dissected out of
globes from the procured tissues

Final ECMIX was collected from the dialysis
tubing and centrifuged for 20 minutes at
14000 rpm. The supernatant was collected
and sterilized under UV for 6-8 hours

Deepithelialized corneas were
extracted in 2.37 ml of 1N
soidum
hydroxide/cornea
until tissues were fully
dissolved

Liquefied cornea solution was dialyzed
against 15 mM HEPES buffer or serum free
DMEM/F12 medium for 48 hours, the dialysis
buffer being replaced once after 24 hours.
pH was asjusted to 7.4

Figure 24: ECMIX preparation scheme. After obtaining eyeballs from a local donor source,
corneas were dissected and de-epithelialized. Deepithelializing the corneas involved
removing all or most of the overlying epithelium. This exposed the stromal layer rich in
the extracellular matrix. Deepithelialized corneas were then subjected to extraction with
1N sodium hydroxide. Extraction was continued until corneas were fully dissolved in the
aqueous solution of the inorganic base. Following completion of extraction, ECMIX
solution was dialyzed against a volume of HEPES buffer and a serum-free DMEM/F12
medium respectively until a physiological pH (e.g., about 7.4) was achieved. Dialyzed
ECMIX solution was collected and centrifuged to get rid of any undissolved tissue debris.
The supernatant was collected and sterilized under UV light for 6 to 8 hours.
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Figure 25: Composition of ECMIX. Fig (A) SDS-PAGE of ECMIX’s proteins stained with
Coomassie brilliant blue. Fig (B) Western immunoblots of the extracellular matrix
composition probed with anti-collagen I antibody (lane 1 and 2), anti-collagen IV antibody
(lane 3) and anti-fibronectin antibody (lane 4).
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Figure 26: SEM micrographs of ECMIX and stroma of the human cornea. Samples for
SEM were processed as described in Methods. Organization of collagen fiber network
visualized in a 54-year old de-epithelialized human cornea (A and B). The characteristic
cornea-stroma fibrous topography appeared to be retained in ECMIX preparation (C and
D). Magnification 100x (A and C), 1000x (B and D).
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Figure 27: Activation of intracellular signal mediators ERK and Akt by ECMIX. Fig (A)
illustrates Western blot analysis and corresponding bar graph representing critical
intracellular signal mediator ERK1 and ERK activation and Fig (B) illustrates Western blot
analysis and corresponding bar graph representing critical intracellular signal mediator Akt
activation, over different treatment time periods (e.g. 5-20 minutes) in primary corneal
epithelial cells treated with ECMIX at 144 µg/ml. Corneal epithelial cells treated with
hepatocyte growth factor (HGF, 10 ng/ml), an established stimulator of ERK cascade was
used as a positive control. Untreated corneal epithelial cells were used as a control group.
Fig (A) indicates a statistically significant increase in p44 and p42 (i.e., phosphorylated
ERK1 and ERK2, respectively) at all treatment time periods, and in HGF treated cells. Fig
(B) indicates a statistically significant increase in pAkt (i.e., phosphorylated Akt) at all
treatment time periods, and in HGF treated cells. Loading of samples in each well was
assured by reprobing the membrane with ERK in (A) and Akt antibody in (B). The bars
represent the mean SD of three different experiments (*p<0.05 phosphorylation in treated
cells versus control at various time points as indicated).
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Figure 28: ECMIX enhanced CDK expressions. Fig (A) illustrates Western blot analysis
and corresponding bar graph representing percent changes in expression of CDK-2 and Fig
(B) illustrates Western blot analysis and corresponding bar graph representing percent
changes in expression of CDK-4 in untreated control primary corneal epithelial cells and
primary corneal epithelial cells treated with different concentrations of ECMIX e.g. 72,
144, 216 µg/ml, respectively. Epithelial cell cultures treated with keratinocyte growth
factor (KGF, 10 ng/ml), a known accelerator of epithelial proliferation, was used as
positive control. Untreated corneal epithelial cells were used as a control group. Fig (A)
depicts a statistically significant increase in expression of CDK-2, and in KGF treated cells
and Fig (B) depicts a statistically significant increase in expression of CDK-4, and in KGF
treated cells, respectively. Loading of samples in each well was assured by reprobing the
membrane with β-actin antibody in (A) and (B). The bars represent the mean SD of three
different experiments (*p<0.05 expression in treated cells versus control at various ECMIX
concentrations as indicated).
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Figure 29: ECMIX–mediated cell cycle protein expression. Fig (A) illustrates Western blot
analysis and corresponding bar graph representing percent changes in expression of Cyclin
A; Fig (B) illustrates Western blot analysis and corresponding bar graph representing
percent changes in expression of p21cip; Fig (C) illustrates Western blot analysis and
corresponding bar graph representing percent changes in expression of Cdc42; Fig (D)
illustrates Western blot analysis and corresponding bar graph representing percent changes
in expression of Cyclin D1 and Fig (E) illustrates Western blot analysis and corresponding
bar graph representing percent changes in expression of Cyclin E in untreated control
primary corneal epithelial cells and primary corneal epithelial cells treated with different
concentrations of ECMIX e.g. 72, 144, 216 µg/ml, respectively. Epithelial cell cultures
treated with keratinocyte growth factor (KGF, 10 ng/ml), a known accelerator of epithelial
proliferation, was used as positive control. Untreated corneal epithelial cells were used as
a control group. Loading of samples in each well was assured by reprobing the membrane
with β-actin antibody in (A-E). The bars represent the mean SD of three different
experiments (*p<0.05 expression in treated cells versus control at various ECMIX
concentrations as indicated).

Figure 30: ECMIX promoted epithelial cell sheets on porcine corneas. Fig (A1&A2) illustrate denuded porcine cornea surfaces prior to
seeding with PCECs. Fig (B2&C2) illustrate microscopical depictions of the surface of porcine corneas treated with PCECs dispersed in
ECMIX, as observed after 4 and 24 hours, respectively. Fig (B1&C1) illustrate microscopical depictions of the surface of porcine control
corneas that were not subjected to ECMIX treatment and seeded with PCECs dispersed in serum-free DMEM/F12 medium, as observed after
4 and 24 hours, respectively. The bars in Fig D represent the quantified cell numbers. Data was taken from at least three different experiments
(*p<0.05 percentage increase in cells in ECMIX treated corneas versus control after 4 and 24 hours post-seeding of cells). Data shown are
mean±standard deviation (SD). (*p<0.05)
111

Figure 31: ECMIX promoted epithelial cell sheets on human corneas. Fig (A) illustrates denuded human cornea surface prior to seeding with HCECs. Fig (B)
illustrates a microscopical depiction of the surface of human cornea treated with HCECs dispersed in ECMIX, as observed 4 hours after initial seeding, Fig (C)
illustrates a microscopical depiction of the surface of human cornea treated with HCECs dispersed in ECMIX, as observed 24 hours after initial seeding, Fig
(D) illustrates a microscopical depiction of the surface of human cornea treated with HCECs dispersed in ECMIX, as observed 48 hours after initial seeding,
Fig (E) illustrates a microscopical depiction of the surface of human cornea treated with HCECs dispersed in ECMIX, as observed 96 hours after initial seeding
and Fig (F) illustrates a microscopical depiction of an intact unepithelialized surface containing the natural epithelium
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Figure 32: Rheological characteristics of ECMIX. (A) viscosity and (B) viscoelasticity (G’Storage modulus, G”- Loss modulus).
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Figure 33: (A) Fabrication of corneal construct by crosslinking ECMIX using 10%
glutaraldehyde solution (B) the chemistry involved in the preparation process:
glutaraldehyde reacts with the ε-amino groups of collagen to form stable cyclic pyridinium
ring cross-links.
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ECMIX

Figure 34: Optical properties of ECMIX. Transmittance (A) and refractive index (B) values
were determined as described in Chapter 2. (*) Human cornea transmittance data included
in (A) and (#) RI data in (B) are as reported in the literature [Transmittance : (Van Den
Berg & Tan, 1962)] [Refractive index : (S. Patel et al., 2004)]. Glycerol was used as
positive control for both transmittance and RI experiments. Data presented for ECMIX is
average of 3 different preparations.
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Figure 35: Optical properties of ECMIX constructs. Transmittance (A) and refractive index
(B) values are determined as described in Methods. (*) Human cornea transmittance data
included in (A) is taken from the reference (Van Den Berg & Tan, 1962) (#) Human
cornea RI data 1.373 and 1.380 included in (B) is as reported in reference (S. Patel et al.,
2004) for anterior and posterior stroma respectively. Data presented for ECMIX construct
is average of 3 different preparations.

Figure 36: Scanning electron micrographs of ECMIX construct. Scanning electron micrographs of ECMIX construct (A)
showed a very similar fibrillar orientation as seen in the human corneal stroma. The typical corneal stroma fibrous
arrangement appeared to be retained in the prepared ECMIX constructs. Samples for SEM were processed as described in
Methods. (Magnification A, B: 150x.)
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Figure 37: Degree of swelling in ECMIX constructs as a function of time at room
temperature.
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Figure 38: Glucose permeation through ECMIX constructs. Percentage change in glucose
permeated as a function of time (0-6 hours) at 340C compared to control human corneas

Figure 39: Corneal cell growth on ECMIX constructs. Morphology of isolated primary cells cultured on the surface of
prepared ECMIX constructs. The denuded construct surface (A) is almost completely populated within 2 days by a
migrating sheet of epithelial cells (B) and spindle-shaped fibroblasts (D) which also infiltrated into the depth of the
construct. After 5 days both epithelial cells (C) and fibroblasts (E) completely covered the surface of the construct.
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Figure 40A: Properties of corneal cells growing on ECMIX constructs: Corneal epithelial cells generated
from the construct surface expressed Cytokeratin-3
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Figure 40B: Properties of corneal cells growing on ECMIX constructs: Epithelial cells growing on the
construct acquired multiple layers
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Figure 40C: Properties of corneal cells growing on ECMIX constructs: while regenerating on the construct surface but
was unable to penetrate into the interior. Fibroblasts were capable of not only populating the surface of the construct
but also infiltrate into the center.
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Figure 41: Sustainability of cell growth on ECMIX constructs: Corneal epithelial cells generated from the
confluent construct surface was successfully regenerated after 15 and 30 days post-seeding on both tissue
culture plate (A) and epithelium denuded human cornea surface (B).
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Table 1: Major ECM components (Michelacci, 2003)
Component

Example

Description

Function

Example of
location

Proteins and

Collagen

glycoproteins

Strong, flexible

Provides flexible

Tendons,

structural protein fiber

strength to tissues

ligaments, bones,
cartilage, many
tissues

Elastin

Flexible, elastic

Allows flexibility and

Skin, cartilage of

structural protein fiber

elastic recoil of tissues

the ear, walls of
arteries

Fibronectin

Rod-like glycoprotein

Binds ECM to cells;

Many tissues of

communicates with cells

the body, for

through integrins

example,
connective tissues

Laminin

Proteoglycans

Glycoproteins

Binds ECM components

In the basal

arranged as a three-

together and to cells;

lamina (basement

pronged fork

communicates with cells

membrane) of

through integrins

epithelial tissues

Shock absorber

Cartilage, bone,

Various

Protein backbone with

types

attached chains of
various
polysaccharides:
Chondroitin sulfate

heart valves
Heparin

Reduces blood clotting

The lining of
some arteries

Hyaluronic acid

Thickens fluid;

Loose fibrous

lubricates

connective tissue
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Table 2: Major ECM components in the eye (Hausman, 2007)
ECM component

Eye Tissue

Aggrecan

Sclera, retina

Agrin

Retina

Akhirin

Epithelium, lens

Chondroadherin

Lens, cornea, retina, sclera

Collagen I

Cornea, sclera, trabecular meshwork

Collagen II

Sclera, vitreous

Collagen III

Sclera

Collagen IV

Cornea, retina, sclera, trabecular meshwork

Collagen V/XI

Cornea, sclera, vitreous

Collagen VI

Sclera

Collagen VII

Cornea

Collagen VIII

Cornea, sclera

Collagen IX

Cornea, lens, vitreous

Collagen X

Sclera

Collagen XI

Sclera

Collagen XII

Sclera

Collagen XIV

Cornea, Sclera

Collagen XV

Sclera

Collagen XVI

Sclera

Collagen XVII

Cornea, sclera, lens, retina, trabecular meshwork

Decorin

Cornea, retina, sclera, trabecular meshwork

Dystonin

Retina
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Table 2: (Continued) Major ECM components in the eye (Hausman, 2007)
ECM component

Eye Tissue

Fibulin-1

Vitreous, cornea, sclera

Fibulin-2

Vitreous, cornea, sclera

Fubulin-5

Cornea, retina, sclera

Fibromodulin

Cornea, sclera

Fibronectin

Cornea, lens, sclera, trabecular meshwork, vitreous

Hyaluranon

Anterior eye tissues, IPM, vitreous

Keratocan

Cornea, eyelid, sclera

Laminin α1

Cornea, Descemet’s membrane, lens, retina, sclera

Laminin α2

Sclera

Laminin α3

Cornea, sclera

Laminin α4

Cornea, Descemet’s membrane, sclera

Laminin α5

Descemet’s membrane, lens, retina, sclera

Laminin β1

Cornea, Descemet’s membrane, lens, retina, sclera

Laminin β2

Cornea, lens, retina, sclera

Laminin β3

Cornea, Descemet’s membrane

Laminin γ1

Retina, sclera

Laminin γ2

Retina

Lumican

Cornea, sclera

Neurocan

Retina

Perlecan

Retina, trabecular meshwork, vitreous

Versican

Cornea, retina, sclera, trabecular meshwork, vitreous

Vitronectin

Sclera
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